Vascular Health and Risk Management

Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes

Skelley JW, Carter BS, Roberts MZ

Vascular Health and Risk Management 2018, 14:419-428

Published Date: 7 December 2018

Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors

Hines DM, Rane P, Patel J, Harrison DJ, Wade RL

Vascular Health and Risk Management 2018, 14:409-418

Published Date: 10 December 2018

Prevalence and risk factors of peripheral artery disease in black Africans with HIV infection: a cross-sectional hospital-based study

Kamdem F, Mapoure Y, Hamadou B, Souksouna F, Doualla MS, Jingi AM, Kenmegne C, Kemta Lekpa F, Kweban Fenkeu J, Imandy G, Nda Mefo’o JP, Luma H

Vascular Health and Risk Management 2018, 14:401-408

Published Date: 6 December 2018

Enhanced external counterpulsation in rehabilitation of erectile dysfunction: a narrative literature review

Raeissadat SA, Javadi A, Allameh F

Vascular Health and Risk Management 2018, 14:393-399

Published Date: 3 December 2018

All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study

Degli Esposti L, Perrone V, Veronesi C, Buda S, Rossini R

Vascular Health and Risk Management 2018, 14:383-392

Published Date: 20 November 2018

Noncardiac Lebanese hospitalized adult patients’ awareness of their coronary artery disease risk factors

Ghaddar F, Salameh P, Saleh N, Farhat F, Chahine R, Lahoud N, Hleyhel M, Zeidan RK

Vascular Health and Risk Management 2018, 14:371-382

Published Date: 8 November 2018

Walking activity during ambulant cardiac rehabilitation is related to maximum working capacity, age, and smoking behavior

Al Najem S, Groll A, Schmermund A, Nowak B, Voigtländer T, Kaltenbach U, Dohmann P, Andresen D, Scharhag J

Vascular Health and Risk Management 2018, 14:361-369

Published Date: 9 November 2018

Anxiety and depression in patients with pulmonary hypertension: impact and management challenges

Bussotti M, Sommaruga M

Vascular Health and Risk Management 2018, 14:349-360

Published Date: 8 November 2018

Brachial–ankle pulse wave velocity, cardio-ankle vascular index, and prognosis

Ato D

Vascular Health and Risk Management 2018, 14:321-348

Published Date: 24 October 2018

Original Research

Use of photoplethysmography to predict mortality in intensive care units

Kock KS, Marques JLB

Vascular Health and Risk Management 2018, 14:311-320

Published Date: 31 October 2018

Assessment of some traditional cardiovascular risk factors in medical doctors in Southern Nigeria

Ambakederemo TE, Chikezie EU

Vascular Health and Risk Management 2018, 14:299-309

Published Date: 24 October 2018

Redefined clinical spectra of diabetic foot syndrome

Shatnawi NJ, Al-Zoubi NA, Hawamdeh H, Khader YS, Omari AEK, Khammash MR

Vascular Health and Risk Management 2018, 14:291-298

Published Date: 18 October 2018

Role of androgens in cardiovascular pathology

Chistiakov DA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN

Vascular Health and Risk Management 2018, 14:283-290

Published Date: 15 October 2018

Idiopathic true aneurysm of distal radial artery: case report

Al-Zoubi NA

Vascular Health and Risk Management 2018, 14:279-281

Published Date: 11 October 2018

Influence of fixed-dose combination perindopril/amlodipine on target organ damage in patients with arterial hypertension with and without ischemic heart disease (results of EPHES trial)

Radchenko GD, Mushtenko LO, Sirenko YM

Vascular Health and Risk Management 2018, 14:265-278

Published Date: 11 October 2018

Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?

Correale M, Ferraretti A, Monaco I, Grazioli D, Di Biase M, Brunetti ND

Vascular Health and Risk Management 2018, 14:253-264

Published Date: 4 October 2018

Original Research

Thromboangiitis obliterans episode: autoimmune flare-up or reinfection?

Mohareri M, Mirhosseini A, Mehraban S, Fazeli B

Vascular Health and Risk Management 2018, 14:247-251

Published Date: 28 September 2018

Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses

Fernet M, Beckerman B, Abreu P, Lins K, Vincent J, Burgess E

Vascular Health and Risk Management 2018, 14:233-246

Published Date: 20 September 2018

Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study)

Nomura S, Taniura T, Shouzu A, Omoto S, Suzuki M, Okuda Y, Ito T

Vascular Health and Risk Management 2018, 14:225-232

Published Date: 18 September 2018

Endothelin-1, nitric oxide, serotonin and high blood pressure in male adolescents

Aflyatumova GN, Nigmatullina R, Sadykova DI, Chibireva MD, Fugetto F, Serra R

Vascular Health and Risk Management 2018, 14:213-223

Published Date: 18 September 2018

Arterial elasticity as a risk factor for early cardiovascular disease among testicular cancer survivors treated with platinum-based chemotherapy: a cross-sectional pilot study

Blaes AH, Mulrooney DA, Vogel RI, Solovey A, Hebbel R, Peterson BA, Neglia JP, Biewen C, Konety SH, Duprez DA

Vascular Health and Risk Management 2018, 14:205-211

Published Date: 10 September 2018

Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana

Antwi-Boasiako C, Campbell AD

Vascular Health and Risk Management 2018, 14:199-204

Published Date: 6 September 2018

Clinical accuracy of the Omron M3 Comfort® and the Omron Evolv® for self-blood pressure measurements in pregnancy and pre-eclampsia – validation according to the Universal Standard Protocol

Topouchian J, Hakobyan Z, Asmar J, Gurgenian S, Zelveian P, Asmar R

Vascular Health and Risk Management 2018, 14:189-197

Published Date: 31 August 2018

Prognosis of patients with pulmonary embolism after rehabilitation

Amoury M, Noack F, Kleeberg K, Stoevesandt D, Lehnigk B, Bethge S, Heinze V, Schlitt A

Vascular Health and Risk Management 2018, 14:183-187

Published Date: 30 August 2018

Prevalence of cardiovascular disease among Bangladeshi adult population: a systematic review and meta-analysis of the studies

Chowdhury MZI, Haque MA, Farhana Z, Anik AM, Chowdhury AH, Haque SM, Marjana LLW, Bristi PD, Mamun BAA, Uddin MJ, Fatema J, Rahman MM, Akter T, Tani TA, Turin TC

Vascular Health and Risk Management 2018, 14:165-181

Published Date: 21 August 2018

Risk factors for deep vein thrombosis of lower extremities in Sudanese women

Ibrahim NA, Hassan FM, Elgari MM, Abdalla SE

Vascular Health and Risk Management 2018, 14:157-164

Published Date: 20 August 2018

Spontaneous internal jugular vein thrombosis as primary presentation of antiphospholipid syndrome: case report

Al-Zoubi NA

Vascular Health and Risk Management 2018, 14:153-155

Published Date: 16 July 2018

Serum markers for asymptomatic atherosclerosis in Egyptian psoriatic patients: study controlled by Doppler estimation of carotid intima-media thickness

Sabry HH, Sabry JH, Daifalla AEH, Akl EM, Hamed AM, Torky AAA

Vascular Health and Risk Management 2018, 14:145-152

Published Date: 9 July 2018

Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance

Shunmoogam N, Naidoo P, Chilton R

Vascular Health and Risk Management 2018, 14:137-143

Published Date: 18 June 2018

Isolated proximal greater saphenous vein thrombosis and the risk of propagation to deep vein thrombosis and pulmonary embolism

Kim SH, Patel N, Thapar K, Pandurangadu AV, Bahl A

Vascular Health and Risk Management 2018, 14:129-135

Published Date: 12 June 2018

The association between the serum level of vitamin D and ischemic heart disease: a study from Jordan

Jarrah MI, Mhaidat NM, Alzoubi KH, Alrabadi N, Alsatari E, Khader Y, Bataineh MF

Vascular Health and Risk Management 2018, 14:119-127

Published Date: 12 June 2018

Anemia and acute coronary syndrome: current perspectives

Stucchi M, Cantoni S, Piccinelli E, Savonitto S, Morici N

Vascular Health and Risk Management 2018, 14:109-118

Published Date: 30 May 2018

Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy

Liu L, Chang B, Wu X, Guo Y, Pan Y, Yang L

Vascular Health and Risk Management 2018, 14:103-108

Published Date: 29 May 2018

Nonadherence to statins: individualized intervention strategies outside the pill box

Lansberg P, Lee A, Lee ZV, Subramaniam K, Setia S

Vascular Health and Risk Management 2018, 14:91-102

Published Date: 24 May 2018

Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada

Senay A, Trottier M, Delisle J, Banica A, Benoit B, Laflamme GY, Malo M, Nguyen H, Ranger P, Fernandes JC

Vascular Health and Risk Management 2018, 14:81-89

Published Date: 8 May 2018

Age–gender distribution of coronary artery calcium score in a black African population in Ghana

Asafu Adjaye Frimpong G, Owusu IK, Anyitey-Kokor IC, Wiafe-Kwakye CSNS, Aboagye E, Coleman NE, Amankwah P, Abaidoo NK

Vascular Health and Risk Management 2018, 14:75-80

Published Date: 4 May 2018

Critical limb ischemia: current challenges and future prospects

Uccioli L, Meloni M, Izzo V, Giurato L, Merolla S, Gandini R

Vascular Health and Risk Management 2018, 14:63-74

Published Date: 26 April 2018

Pitfalls in the ankle-brachial index and brachial-ankle pulse wave velocity

Ato D

Vascular Health and Risk Management 2018, 14:41-62

Published Date: 3 April 2018

Patient knowledge on stroke risk factors, symptoms and treatment options

Faiz KW, Sundseth A, Thommessen B, Rønning OM

Vascular Health and Risk Management 2018, 14:37-40

Published Date: 7 February 2018

Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease

Power TP, Ke X, Zhao Z, Bonine NG, Cziraky MJ, Grabner M, Barron JJ, Quimbo R, Vangerow B, Toth PP

Vascular Health and Risk Management 2018, 14:23-36

Published Date: 5 February 2018

Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice

Vimalesvaran K, Dockrill SJ, Gorog DA

Vascular Health and Risk Management 2018, 14:13-21

Published Date: 9 January 2018

Postural tachycardia syndrome: current perspectives

Wells R, Spurrier AJ, Linz D, Gallagher C, Mahajan R, Sanders P, Page A, Lau DH

Vascular Health and Risk Management 2018, 14:1-11

Published Date: 29 December 2017

Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants

ten Cate H, Henskens YMC, Lancé MD

Vascular Health and Risk Management 2017, 13:457-467

Published Date: 13 December 2017

Extracorporeal ultrafiltration for acute heart failure: patient selection and perspectives

Milazzo V, Cosentino N, Marenzi G

Vascular Health and Risk Management 2017, 13:449-456

Published Date: 11 December 2017

Pelvic vein incompetence: clinical perspectives

Riding DM, Hansrani V, McCollum C

Vascular Health and Risk Management 2017, 13:439-447

Published Date: 27 November 2017

Efficacy of noninvasive cardiac imaging tests in diagnosis and management of stable coronary artery disease

Mordi IR, Badar AA, Irving RJ, Weir-McCall JR, Houston JG, Lang CC

Vascular Health and Risk Management 2017, 13:427-437

Published Date: 21 November 2017

Endothelial dysfunction assessment by flow-mediated dilation in a high-altitude population

Calderón-Gerstein WS, López-Peña A, Macha-Ramírez R, Bruno-Huamán A, Espejo-Ramos R, Vílchez-Bravo S, Ramírez-Breña M, Damián-Mucha M, Matos-Mucha A

Vascular Health and Risk Management 2017, 13:421-426

Published Date: 21 November 2017

Treatment of pulmonary hypertension with left heart disease: a concise review

Desai A, Desouza SA

Vascular Health and Risk Management 2017, 13:415-420

Published Date: 6 November 2017

Quick reference guide to apixaban [Corrigendum]

Hurst KV, O'Callaghan JM, Handa A

Vascular Health and Risk Management 2017, 13:413-414

Published Date: 26 October 2017

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists

Yugar-Toledo JC, Modolo R, de Faria AP, Moreno H

Vascular Health and Risk Management 2017, 13:403-411

Published Date: 16 October 2017

Implementing clinical process management of vascular wounds in a tertiary facility: impact evaluation of a performance improvement project

Avruscio G, Tocco-Tussardi I, Bordignon G, Vindigni V

Vascular Health and Risk Management 2017, 13:393-401

Published Date: 16 October 2017

Factors associated with high brachial–ankle pulse wave velocity in non-hypertensive and appropriately treated hypertensive patients with atherosclerotic risk factors

Ato D, Sawayama T

Vascular Health and Risk Management 2017, 13:383-392

Published Date: 10 October 2017

Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives

Yandrapalli S, Andries G, Biswas M, Khera S

Vascular Health and Risk Management 2017, 13:369-382

Published Date: 5 October 2017

Evaluation of vitamin D levels in relation to coronary CT angiographic findings in an Iranian population

Moradi M, Foroutanfar A

Vascular Health and Risk Management 2017, 13:361-367

Published Date: 4 October 2017

Right ventricular systolic function in hypertensive heart failure

Oketona OA, Balogun MO, Akintomide AO, Ajayi OE, Adebayo RA, Mene-Afejuku TO, Oketona OT, Bamikole OJ

Vascular Health and Risk Management 2017, 13:353-360

Published Date: 27 September 2017

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives

Catapano AL, Pirillo A, Norata GD

Vascular Health and Risk Management 2017, 13:343-351

Published Date: 4 September 2017

Review

Evaluation of bleeding in patients receiving direct oral anticoagulants

Hellenbart EL, Faulkenberg KD, Finks SW

Vascular Health and Risk Management 2017, 13:325-342

Published Date: 23 August 2017

Endothelial dysfunction in patients with Buerger disease

Igari K, Kudo T, Toyofuku T, Inoue Y

Vascular Health and Risk Management 2017, 13:317-323

Published Date: 23 August 2017

Soluble ST2 correlates with some indicators of right ventricular function in hypertensive heart failure

Ojji DB, Lecour S, Adeyemi OM, Sliwa K

Vascular Health and Risk Management 2017, 13:311-316

Published Date: 16 August 2017

Evaluation of pain during endovenous laser ablation of the great saphenous vein with ultrasound-guided femoral nerve block

Al Wahbi AM

Vascular Health and Risk Management 2017, 13:305-309

Published Date: 10 August 2017

Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance

Aghel N, Delgado DH, Lipton JH

Vascular Health and Risk Management 2017, 13:293-303

Published Date: 4 August 2017

Reversal of direct oral anticoagulants

Almegren M

Vascular Health and Risk Management 2017, 13:287-292

Published Date: 19 July 2017

Original Research

Hypertension and blood pressure variability management practices among physicians in Singapore

Setia S, Subramaniam K, Tay JC, Teo BW

Vascular Health and Risk Management 2017, 13:275-285

Published Date: 17 July 2017

Use of angiotensin-converting enzyme inhibitors and freedom from amputation after lower extremity revascularization

Kray JE, Dombrovskiy VY, Vogel TR

Vascular Health and Risk Management 2017, 13:269-274

Published Date: 14 July 2017

Quick reference guide to apixaban

Hurst KV, O'Callaghan JM, Handa A

Vascular Health and Risk Management 2017, 13:263-267

Published Date: 10 July 2017

Focusing on a complete blood cell parameter: mean platelet volume levels may be a predictor of coronary slow flow

Yılmaz M, Dağlı MN, Uku Ö, Bilen MN, Korkmaz H, Erdem K, Kurtoğlu E

Vascular Health and Risk Management 2017, 13:255-261

Published Date: 7 July 2017

Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy

Jetty V, Glueck CJ, Lee K, Goldenberg N, Prince M, Kumar A, Goldenberg M, Anand I, Wang P

Vascular Health and Risk Management 2017, 13:247-253

Published Date: 6 July 2017

Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study

Ermini G, Perrone V, Veronesi C, Degli Esposti L, Di Pasquale G

Vascular Health and Risk Management 2017, 13:239-246

Published Date: 5 July 2017

Annual deterioration of renal function in hypertensive patients with and without diabetes

Polonia J, Azevedo A, Monte M, Silva JA, Bertoquini S

Vascular Health and Risk Management 2017, 13:231-237

Published Date: 26 June 2017

Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism

Mesquita PN, Dornelas Leão Leite AP, Chagas Crisostomo S, Veras Filho E, Cunha Xavier L, Bandeira F

Vascular Health and Risk Management 2017, 13:225-229

Published Date: 22 June 2017

Cost-utility analysis comparing laparoscopic vs open aortobifemoral bypass surgery

Krog AH, Sahba M, Pettersen EM, Wisloff T, Sundhagen JO, Kazmi SSH

Vascular Health and Risk Management 2017, 13:217-224

Published Date: 19 June 2017

Comparison of the acute-phase response after laparoscopic versus open aortobifemoral bypass surgery: a substudy of a randomized controlled trial [Erratum]

Krog AH, Sahba M, Pettersen EM, Sandven I, Thorsby PM, Jørgensen JJ, Sundhagen JO, Kazmi SS

Vascular Health and Risk Management 2017, 13:215-216

Published Date: 19 June 2017

Worksite-based cardiovascular risk screening and management: a feasibility study

Padwal R, Rashead M, Snider J, Morrin L, Lehman A, Campbell NRC

Vascular Health and Risk Management 2017, 13:209-213

Published Date: 12 June 2017

Reference values assessment in a Mediterranean population for small dense low-density lipoprotein concentration isolated by an optimized precipitation method

Fernández-Cidón B, Padró-Miquel A, Alía-Ramos P, Castro-Castro MJ, Fanlo-Maresma M, Dot-Bach D, Valero-Politi J, Pintó-Sala X, Candás-Estébanez B

Vascular Health and Risk Management 2017, 13:201-207

Published Date: 6 June 2017

Totally laparoscopic aortobifemoral bypass surgery in the treatment of aortoiliac occlusive disease or abdominal aortic aneurysms – a systematic review and critical appraisal of literature

Helgetveit I, Krog AH

Vascular Health and Risk Management 2017, 13:187-199

Published Date: 18 May 2017

Pediatric ventricular assist devices: current challenges and future prospects

Burki S, Adachi I

Vascular Health and Risk Management 2017, 13:177-185

Published Date: 15 May 2017

Patient-perceived health-related quality of life before and after laparoscopic aortobifemoral bypass

Kazmi SSH, Krog AH, Berge ST, Sundhagen JO, Sahba M, Falk RS

Vascular Health and Risk Management 2017, 13:169-176

Published Date: 12 May 2017

Infrainguinal open reconstruction: a review of surgical considerations and expected outcomes

Komshian SR, Lu K, Pike SL, Siracuse JJ

Vascular Health and Risk Management 2017, 13:161-168

Published Date: 8 May 2017

Pulmonary hypertension in Nigerian adults with sickle cell anemia

Amadi VN, Balogun MO, Akinola NO, Adebayo RA, Akintomide AO

Vascular Health and Risk Management 2017, 13:153-160

Published Date: 8 May 2017

Original Research

The changing trend of cardiovascular disease and its clinical characteristics in Ethiopia: hospital‑based observational study

Tefera YG, Abegaz TM, Abebe TB, Mekuria AB

Vascular Health and Risk Management 2017, 13:143-151

Published Date: 21 April 2017

Impact of around-the-clock in-house cardiology fellow coverage on door-to-balloon time in an academic medical center

Kohan LC, Nagarajan V, Millard MA, Loguidice MJ, Fauber NM, Keeley EC

Vascular Health and Risk Management 2017, 13:139-142

Published Date: 18 April 2017

High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study

Goss F, Brachmann J, Hamm CW, Haerer W, Reifart N, Levenson B

Vascular Health and Risk Management 2017, 13:127-137

Published Date: 6 April 2017

Original Research

DPP-4 inhibitor treatment: β-cell response but not HbA1c reduction is dependent on the duration of diabetes

Kozlovski P, Bhosekar V, Foley JE

Vascular Health and Risk Management 2017, 13:123-126

Published Date: 31 March 2017

New pharmacological and technological management strategies in heart failure

Chaudhry SP, Stewart GC

Vascular Health and Risk Management 2017, 13:111-121

Published Date: 21 March 2017

Early discharge compared with ordinary discharge after percutaneous coronary intervention – a systematic review and meta-analysis of safety and cost

Abdelnoor M, Andersen JG, Arnesen H, Johansen O

Vascular Health and Risk Management 2017, 13:101-109

Published Date: 20 March 2017

Aerobic fitness is associated with low cardiovascular disease risk: the impact of lifestyle on early risk factors for atherosclerosis in young healthy Swedish individuals – the Lifestyle, Biomarker, and Atherosclerosis study

Fernström M, Fernberg U, Eliason G, Hurtig-Wennlöf A

Vascular Health and Risk Management 2017, 13:91-99

Published Date: 15 March 2017

Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device

Alipour A, Wintgens LIS, Swaans MJ, Balt JC, Rensing BJWM, Boersma LVA

Vascular Health and Risk Management 2017, 13:81-90

Published Date: 6 March 2017

Prognostic indices among hypertensive heart failure patients in Nigeria: the roles of 24-hour Holter electrocardiography and 6-minute walk test

Mene-Afejuku TO, Balogun MO, Akintomide AO, Adebayo RA

Vascular Health and Risk Management 2017, 13:71-79

Published Date: 27 February 2017

Questionable accuracy of home blood pressure measurements in the obese population – Validation of the Microlife WatchBP O3® and Omron RS6® devices according to the European Society of Hypertension-International Protocol

Azaki A, Diab R, Harb A, Asmar R, Chahine MN

Vascular Health and Risk Management 2017, 13:61-69

Published Date: 27 February 2017

Prevalence of mild cognitive impairment in employable patients after acute coronary event in cardiac rehabilitation

Salzwedel A, Heidler MD, Haubold K, Schikora M, Reibis R, Wegscheider K, Jöbges M, Völler H

Vascular Health and Risk Management 2017, 13:55-60

Published Date: 23 February 2017

An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes

Messana JA, Schwartz SS, Townsend RR

Vascular Health and Risk Management 2017, 13:43-54

Published Date: 17 February 2017

Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy

Tarantino N, Santoro F, De Gennaro L, Correale M, Guastafierro F, Gaglione A, Di Biase M, Brunetti ND

Vascular Health and Risk Management 2017, 13:29-41

Published Date: 16 February 2017

An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia

Bove M, Cicero AFG, Veronesi M, Borghi C

Vascular Health and Risk Management 2017, 13:23-28

Published Date: 8 February 2017

Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006–2012

An R, Wang PP

Vascular Health and Risk Management 2017, 13:15-21

Published Date: 20 January 2017

Complex neurological symptoms in bilateral thalamic stroke due to Percheron artery occlusion

Caruso P, Manganotti P, Moretti R

Vascular Health and Risk Management 2017, 13:11-14

Published Date: 22 December 2016

Inverse relationship of cardioankle vascular index with BMI in healthy Japanese subjects: a cross-sectional study

Nagayama D, Imamura H, Sato Y, Yamaguchi T, Ban N, Kawana H, Ohira M, Saiki A, Shirai K, Tatsuno I

Vascular Health and Risk Management 2017, 13:1-9

Published Date: 21 December 2016

Prevalence of cardiovascular risk factors among workers at a private tertiary center in Angola

Paquissi FC, Manuel V, Manuel A, Mateus GL, David B, Béu G, Castela A

Vascular Health and Risk Management 2016, 12:497-503

Published Date: 14 December 2016

Results of a venous thromboembolism prophylaxis program for hospitalized patients

Cardoso LF, Krokoscz DV, Paiva EF, Furtado IS, Mattar Jr J, de Souza e Sá MM, de Lira AC

Vascular Health and Risk Management 2016, 12:491-496

Published Date: 12 December 2016

Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia

Benes LB, Bassi NS, Davidson MH

Vascular Health and Risk Management 2016, 12:481-490

Published Date: 12 December 2016

Platelet count and platelet indices in women with preeclampsia

AlSheeha MA, Alaboudi RS, Alghasham MA, Iqbal J, Adam I

Vascular Health and Risk Management 2016, 12:477-480

Published Date: 21 November 2016

Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores

Schellings DAAM, Adiyaman A, Dambrink JH, Gosselink ATM, Kedhi E, Roolvink V, Ottervanger JP, van't Hof AWJ

Vascular Health and Risk Management 2016, 12:471-476

Published Date: 21 November 2016

Advances in the management of heart failure: the role of ivabradine

Müller-Werdan U, Stöckl G, Werdan K

Vascular Health and Risk Management 2016, 12:453-470

Published Date: 17 November 2016

Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence

Antza C, Stabouli S, Kotsis V

Vascular Health and Risk Management 2016, 12:443-451

Published Date: 15 November 2016

A stress-related explanation to the increased blood pressure and its course following ischemic stroke

Kvistad CE, Oygarden H, Logallo N, Thomassen L, Waje-Andreassen U, Moen G, Naess H

Vascular Health and Risk Management 2016, 12:435-442

Published Date: 11 November 2016

Review

Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders

Gupta S

Vascular Health and Risk Management 2016, 12:421-433

Published Date: 10 November 2016

A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus

Derosa G, Maffioli P

Vascular Health and Risk Management 2016, 12:415-419

Published Date: 9 November 2016

Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence

Alhaddad IA, Hamoui O, Hammoudeh A, Mallat S

Vascular Health and Risk Management 2016, 12:407-413

Published Date: 27 October 2016

Impact of sodium–glucose cotransporter 2 inhibitors on blood pressure

Reed JW

Vascular Health and Risk Management 2016, 12:393-405

Published Date: 27 October 2016

International normalized ratio self-testing and self-management: improving patient outcomes

Pozzi M, Mitchell J, Henaine AM, Hanna N, Safi O, Henaine R

Vascular Health and Risk Management 2016, 12:387-392

Published Date: 12 October 2016

Carbohydrate composition of circulating multiple-modified low-density lipoprotein

Zakiev ER, Sobenin IA, Sukhorukov VN, Myasoedova VA, Ivanova EA, Orekhov AN

Vascular Health and Risk Management 2016, 12:379-385

Published Date: 14 October 2016

Comparison of the acute-phase response after laparoscopic versus open aortobifemoral bypass surgery: a substudy of a randomized controlled trial

Krog AH, Sahba M, Pettersen EM, Sandven I, Thorsby PM, Jørgensen JJ, Sundhagen JO, Kazmi SS

Vascular Health and Risk Management 2016, 12:371-378

Published Date: 26 September 2016

Overview of guidelines for the management of dyslipidemia: EU perspectives

Giner-Galvañ V, Esteban-Giner MJ, Pallarés-Carratalá V

Vascular Health and Risk Management 2016, 12:357-369

Published Date: 6 September 2016

Critical appraisal of paclitaxel balloon angioplasty for femoral–popliteal arterial disease

Herten M, Torsello GB, Schönefeld E, Stahlhoff S

Vascular Health and Risk Management 2016, 12:341-356

Published Date: 29 August 2016

Blood pressure and fasting lipid changes after 24 weeks’ treatment with vildagliptin: a pooled analysis in >2,000 previously drug-naïve patients with type 2 diabetes mellitus

Evans M, Schweizer A, Foley JE

Vascular Health and Risk Management 2016, 12:337-340

Published Date: 18 August 2016

Risk impact of edoxaban in the management of stroke and venous thromboembolism

Hurst KV, O’Callaghan JM, Handa A

Vascular Health and Risk Management 2016, 12:329-335

Published Date: 11 August 2016

Predictors of high central blood pressure in young with isolated systolic hypertension

Radchenko GD, Torbas OO, Sirenko YM

Vascular Health and Risk Management 2016, 12:321-328

Published Date: 2 August 2016

Effect of nitroglycerin administration on cardio-ankle vascular index

Shimizu K, Yamamoto T, Takahashi M, Sato S, Noike H, Shirai K

Vascular Health and Risk Management 2016, 12:313-319

Published Date: 3 August 2016

Detection of peripheral arterial disease with an improved automated device: comparison of a new oscillometric device and the standard Doppler method

Špan M, Geršak G, Millasseau SC, Meža M, Košir A

Vascular Health and Risk Management 2016, 12:305-311

Published Date: 29 July 2016

Biomarkers and the prediction of atrial fibrillation: state of the art

O’Neal WT, Venkatesh S, Broughton ST, Griffin WF, Soliman EZ

Vascular Health and Risk Management 2016, 12:297-303

Published Date: 18 July 2016

Matrix metalloproteinases in exercise and obesity

Jaoude J, Koh Y

Vascular Health and Risk Management 2016, 12:287-295

Published Date: 14 July 2016

Association between perceived lifetime risk of cardiovascular disease and calculated risk in a male population in Brazil

de Lima Jr MM, da Silva GR, Jansem Filho SS, Granja F

Vascular Health and Risk Management 2016, 12:279-286

Published Date: 22 June 2016

Noninvasive FFR derived from coronary CT angiography in the management of coronary artery disease: technology and clinical update

Nakanishi R, Budoff MJ

Vascular Health and Risk Management 2016, 12:269-278

Published Date: 22 June 2016

Impact of selective platelet inhibition in reducing cardiovascular risk - role of vorapaxar

Cheng JWM

Vascular Health and Risk Management 2016, 12:263-268

Published Date: 14 June 2016

Original Research

Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study

Haider A, Yassin A, Haider KS, Doros G, Saad F, Rosano GM

Vascular Health and Risk Management 2016, 12:251-261

Published Date: 14 June 2016

Review

SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives

Gurgle HE, White K, McAdam-Marx C

Vascular Health and Risk Management 2016, 12:239-249

Published Date: 4 June 2016

Elevated risk of venous thromboembolic events in patients with inflammatory myopathies

Nowak M, Królak-Nowak K, Sobolewska-Włodarczyk A, Fichna J, Włodarczyk M

Vascular Health and Risk Management 2016, 12:233-238

Published Date: 3 June 2016

Risk factors for amputation in extremities vascular injuries in Saudi Arabia

Al Wahbi A, Aldakhil S, Al Turki S, El Kayali A, Al Kohlani H, Al Showmer A

Vascular Health and Risk Management 2016, 12:229-232

Published Date: 24 May 2016

Cardiovascular risk factor control is insufficient in young patients with coronary artery disease

Christiansen MK, Jensen JM, Brøndberg AK, Bøtker HE, Jensen HK

Vascular Health and Risk Management 2016, 12:219-227

Published Date: 25 May 2016

The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study

Haas S, Holberg G, Kreutz R, Lassen MR, Mantovani L, Haupt V, Vogtländer K, Turpie AGG

Vascular Health and Risk Management 2016, 12:209-218

Published Date: 18 May 2016

Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date

Barkat M, Torella F, Antoniou GA

Vascular Health and Risk Management 2016, 12:199-208

Published Date: 12 May 2016

Review

PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab

Blom DJ, Dent R, Castro RC, Toth PP

Vascular Health and Risk Management 2016, 12:185-197

Published Date: 9 May 2016

Review

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease

Toth PP

Vascular Health and Risk Management 2016, 12:171-183

Published Date: 6 May 2016

Review

Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction

Henry CA, Lyon RA, Ling H

Vascular Health and Risk Management 2016, 12:163-169

Published Date: 19 April 2016

Management of intracerebral hemorrhage – use of statins

Van Matre ET, Sherman DS, Kiser TH

Vascular Health and Risk Management 2016, 12:153-161

Published Date: 18 April 2016

Mortality in primary angioplasty patients starting antiplatelet therapy with prehospital prasugrel or clopidogrel: a 1-year follow-up from the European MULTIPRAC Registry

Goldstein P, Grieco N, Ince H, Danchin N, Ramos Y, Goedicke J, Clemmensen P

Vascular Health and Risk Management 2016, 12:143-151

Published Date: 19 April 2016

Targeting heart failure with preserved ejection fraction: current status and future prospects

Kanwar M, Walter C, Clarke M, Patarroyo-Aponte M

Vascular Health and Risk Management 2016, 12:129-141

Published Date: 15 April 2016

Endovascular revascularization for aortoiliac atherosclerotic disease

Aggarwal V, Waldo SW, Armstrong EJ

Vascular Health and Risk Management 2016, 12:117-127

Published Date: 29 March 2016

Review

Cognitive impairment and stroke in elderly patients

Lo Coco D, Lopez G, Corrao S

Vascular Health and Risk Management 2016, 12:105-116

Published Date: 24 March 2016

A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease

Maeder MT, Schoch OD, Rickli H

Vascular Health and Risk Management 2016, 12:85-103

Published Date: 21 March 2016

Original Research

Prevalence and correlates of coronary heart disease: first population-based study in Lebanon

Zeidan RK, Farah R, Chahine MN, Asmar R, Hosseini H, Salameh P, Pathak A

Vascular Health and Risk Management 2016, 12:75-84

Published Date: 17 March 2016

Atrial fibrillation and silent stroke: links, risks, and challenges

Hahne K, Mönnig G, Samol A

Vascular Health and Risk Management 2016, 12:65-74

Published Date: 7 March 2016

Type II endoleaks: challenges and solutions

Brown A, Saggu GK, Bown MJ, Sayers RD, Sidloff DA

Vascular Health and Risk Management 2016, 12:53-63

Published Date: 2 March 2016

Edoxaban in venous thromboembolism and stroke prevention: an appraisal

Proietti M, Lip GYH

Vascular Health and Risk Management 2016, 12:45-51

Published Date: 29 February 2016

Review

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab

Hu TY, Vaidya VR, Asirvatham SJ

Vascular Health and Risk Management 2016, 12:35-44

Published Date: 17 February 2016

Review

Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era

Toth PP

Vascular Health and Risk Management 2016, 12:23-34

Published Date: 10 February 2016

Original Research

The cost of inpatient death associated with acute coronary syndrome

Page II RL, Ghushchyan V, Van Den Bos J, Gray TJ, Hoetzer GL, Bhandary D, Nair KV

Vascular Health and Risk Management 2016, 12:13-21

Published Date: 3 February 2016

Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?

Foley JE, Bhosekar V, Kawamori R

Vascular Health and Risk Management 2016, 12:9-12

Published Date: 21 January 2016

Critical evaluation of the MitraClip system in the management of mitral regurgitation

Deuschl F, Schofer N, Lubos E, Blankenberg S, Schäfer U

Vascular Health and Risk Management 2016, 12:1-8

Published Date: 11 January 2016

Fractional flow reserve-guided percutaneous coronary intervention: where to after FAME 2?

van de Hoef TP, Meuwissen M, Piek JJ

Vascular Health and Risk Management 2015, 11:613-622

Published Date: 3 December 2015

Personalized medicine and stroke prevention: where are we?

Kim J, Thrift AG, Nelson MR, Bladin CF, Cadilhac DA

Vascular Health and Risk Management 2015, 11:601-611

Published Date: 2 December 2015

Preseason preparation training and endothelial function in elite professional soccer players

Androulakis NE, Koundourakis NE, Nioti E, Spatharaki P, Hatzisymeon D, Miminas I, Alexandrakis MG

Vascular Health and Risk Management 2015, 11:595-599

Published Date: 26 November 2015

Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy

Blaes AH, Rehman A, Vock DM, Luo X, Menge M, Yee D, Missov E, Duprez D

Vascular Health and Risk Management 2015, 11:591-594

Published Date: 24 November 2015

Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine

Herath HMM, Weerarathna TP, Umesha D

Vascular Health and Risk Management 2015, 11:583-589

Published Date: 13 November 2015

Case report

Reversal of statin-induced memory dysfunction by co-enzyme Q10: a case report

Okeahialam BN

Vascular Health and Risk Management 2015, 11:579-581

Published Date: 6 November 2015

Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study

Pfohl M, Siegmund T, Pscherer S, Pegelow K, Seufert J

Vascular Health and Risk Management 2015, 11:569-578

Published Date: 6 November 2015

Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital

Sangsawang T, Sriwijitkamol A

Vascular Health and Risk Management 2015, 11:563-567

Published Date: 4 November 2015

Review

Managing atrial fibrillation in the very elderly patient: challenges and solutions

Karamichalakis N, Letsas KP, Vlachos K, Georgopoulos S, Bakalakos A, Efremidis M, Sideris A

Vascular Health and Risk Management 2015, 11:555-562

Published Date: 27 October 2015

Progression of carotid-artery disease in type 2 diabetic patients: a cohort prospective study

Bosevski M, Stojanovska L

Vascular Health and Risk Management 2015, 11:549-553

Published Date: 16 October 2015

A comparative cohort study of totally laparoscopic and open aortobifemoral bypass for the treatment of advanced atherosclerosis

Kazmi SS, Jørgensen JJ, Sundhagen JO, Krog AH, Flørenes TL, Kollerøs D, Abdelnoor M

Vascular Health and Risk Management 2015, 11:541-547

Published Date: 18 September 2015

The MGuard coronary stent: safety, efficacy, and clinical utility

Gracida M, Romaguera R, Jacobi F, Gómez-Hospital JA, Cequier A

Vascular Health and Risk Management 2015, 11:533-539

Published Date: 18 September 2015

LDL electronegativity index: a potential novel index for predicting cardiovascular disease

Ivanova EA, Bobryshev YV, Orekhov AN

Vascular Health and Risk Management 2015, 11:525-532

Published Date: 28 August 2015

Review

Comparison of bioavailability of krill oil versus fish oil and health effect

Ulven SM, Holven KB

Vascular Health and Risk Management 2015, 11:511-524

Published Date: 28 August 2015

Comparing withdrawal and not withdrawal of life-sustaining treatment among patients who died from stroke

Helvig E, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2015, 11:507-510

Published Date: 3 September 2015

Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries?

Noubiap JJ, Nansseu JR

Vascular Health and Risk Management 2015, 11:503-506

Published Date: 25 August 2015

Review

New developments in atherosclerosis: clinical potential of PCSK9 inhibition

Giunzioni I, Tavori H

Vascular Health and Risk Management 2015, 11:493-501

Published Date: 24 August 2015

Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in

Blann A

Vascular Health and Risk Management 2015, 11:489-492

Published Date: 20 August 2015

Subcutaneous adipose tissue plays a beneficial effect on subclinical atherosclerosis in young survivors of acute lymphocytic leukemia

Siviero-Miachon AA, Spinola-Castro AM, Lee ML, Monteiro CM, Carvalho AC, Calixto AR, Geloneze B, Guerra-Junior G

Vascular Health and Risk Management 2015, 11:479-488

Published Date: 18 August 2015

Review

Prevention of venous thromboembolism in patients undergoing bariatric surgery

Bartlett MA, Mauck KF, Daniels PR

Vascular Health and Risk Management 2015, 11:461-477

Published Date: 17 August 2015

Review

Assessing the risk of recurrent venous thromboembolism – a practical approach

Fahrni J, Husmann M, Gretener SB, Keo HH

Vascular Health and Risk Management 2015, 11:451-459

Published Date: 17 August 2015

Review

Secondary stroke prevention: challenges and solutions

Esenwa C, Gutierrez J

Vascular Health and Risk Management 2015, 11:437-450

Published Date: 7 August 2015

Sex differences in predictors of ischemic stroke: current perspectives

Samai AA, Martin-Schild S

Vascular Health and Risk Management 2015, 11:427-436

Published Date: 27 July 2015

Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database

Detournay B, Halimi S, Robert J, Deschaseaux C, Dejager S

Vascular Health and Risk Management 2015, 11:417-425

Published Date: 17 July 2015

Review

Preeclampsia: long-term consequences for vascular health

Amaral LM, Cunningham Jr MW, Cornelius DC, LaMarca B

Vascular Health and Risk Management 2015, 11:403-415

Published Date: 15 July 2015

Original Research

Feasibility and safety of rehabilitation after venous thromboembolism

Noack F, Schmidt B, Amoury M, Stoevesandt D, Gielen S, Pflaumbaum B, Girschick C, Völler H, Schlitt A

Vascular Health and Risk Management 2015, 11:397-401

Published Date: 13 July 2015

Review

Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence

Bishu K, Armstrong EJ

Vascular Health and Risk Management 2015, 11:387-395

Published Date: 13 July 2015

Preoperative optimization of the vascular surgery patient

Zhan HT, Purcell ST, Bush RL

Vascular Health and Risk Management 2015, 11:379-385

Published Date: 1 July 2015

Role of diclofenac in the prevention of postpericardiotomy syndrome after cardiac surgery

Sevuk U, Baysal E, Altindag R, Yaylak B, Adiyaman MS, Ay N, Alp V, Beyazit U

Vascular Health and Risk Management 2015, 11:373-378

Published Date: 30 June 2015

Original Research

Physical activity in patients with type 2 diabetes and hypertension – insights into motivations and barriers from the MOBILE study

Duclos M, Dejager S, Postel-Vinay N, di Nicola S, Quéré S, Fiquet B

Vascular Health and Risk Management 2015, 11:361-371

Published Date: 29 June 2015

Heart rate variability and arrhythmic patterns of 24-hour Holter electrocardiography among Nigerians with cardiovascular diseases

Adebayo RA, Ikwu AN, Balogun MO, Akintomide AO, Ajayi OE, Adeyeye VO, Mene-Afejuku TO, Bamikole OJ, Ogunyemi SA, Ajibare AO, Oketona OA

Vascular Health and Risk Management 2015, 11:353-359

Published Date: 29 June 2015

Review

Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism

Chan NC, Bhagirath V, Eikelboom JW

Vascular Health and Risk Management 2015, 11:343-351

Published Date: 26 June 2015

Review

Lipidomics in vascular health: current perspectives

Kolovou G, Kolovou V, Mavrogeni S

Vascular Health and Risk Management 2015, 11:333-342

Published Date: 12 June 2015

Review

Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation

Ment J

Vascular Health and Risk Management 2015, 11:317-332

Published Date: 10 June 2015

Original Research

Blood pressure control to prevent decline in cognition after stroke

Ihle-Hansen H, Thommessen B, Fagerland MW, Øksengård AR, Wyller TB, Engedal K, Fure B

Vascular Health and Risk Management 2015, 11:311-316

Published Date: 9 June 2015

Original Research

Doctors' knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore

Setia S, Fung SSW, Waters DD

Vascular Health and Risk Management 2015, 11:303-310

Published Date: 4 June 2015

Case report

High-flow bypass and wrap-clipping for ruptured blood blister-like aneurysm of the internal carotid artery using intraoperative monitoring of cerebral hemodynamics

Kubo Y, Koji T, Yoshida K, Saito H, Ogawa A, Ogasawara K

Vascular Health and Risk Management 2015, 11:297-302

Published Date: 3 June 2015

Review

Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond

Singh JSS, Lang CC

Vascular Health and Risk Management 2015, 11:283-295

Published Date: 1 June 2015

Review

Current and emerging strategies in the management of venous thromboembolism: benefit–risk assessment of dabigatran

Fanola CL

Vascular Health and Risk Management 2015, 11:271-282

Published Date: 27 May 2015

Epoprostenol sodium for treatment of pulmonary arterial hypertension

Saito Y, Nakamura K, Akagi S, Sarashina T, Ejiri K, Miura A, Ogawa A, Matsubara H, Ito H

Vascular Health and Risk Management 2015, 11:265-270

Published Date: 14 May 2015

Lipid-modifying therapy in the elderly

Hamilton-Craig I, Colquhoun D, Kostner K, Woodhouse S, d'Emden M

Vascular Health and Risk Management 2015, 11:251-263

Published Date: 14 May 2015

Comparison of the BPLab® sphygmomanometer for ambulatory blood pressure monitoring with mercury sphygmomanometry in pregnant women: validation study according to the British Hypertension Society protocol

Dorogova IV, Panina ES

Vascular Health and Risk Management 2015, 11:245-249

Published Date: 13 April 2015

Review

Alogliptin benzoate for management of type 2 diabetes

Saisho Y

Vascular Health and Risk Management 2015, 11:229-243

Published Date: 10 April 2015

Review

Breast cancer therapy and cardiovascular risk: focus on trastuzumab

Sandoo A, Kitas GD, Carmichael AR

Vascular Health and Risk Management 2015, 11:223-228

Published Date: 7 April 2015

Endovascular repair of a life-threatening radiation-induced ruptured false aneurysm of the intrathoracic left subclavian artery: case report

Hizette P, Horn D, Lemaitre J, Segers B

Vascular Health and Risk Management 2015, 11:219-222

Published Date: 31 March 2015

Original Research

Experimental study of sutureless vascular anastomosis with use of glued prosthesis in rabbits

Vokrri L, Qavdarbasha A, Rudari H, Ahmetaj H, Manxhuka-Kërliu S, Hyseni N, Porcu P, Cinquin P, Sessa C

Vascular Health and Risk Management 2015, 11:211-217

Published Date: 27 March 2015

Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?

Scherer DJ, Nicholls SJ

Vascular Health and Risk Management 2015, 11:203-209

Published Date: 25 March 2015

Review

Virtual reality simulation for the optimization of endovascular procedures: current perspectives

Rudarakanchana N, Van Herzeele I, Desender L, Cheshire NJW

Vascular Health and Risk Management 2015, 11:195-202

Published Date: 10 March 2015

Original Research

Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease

Chen DC, Armstrong EJ, Singh GD, Amsterdam EA, Laird JR

Vascular Health and Risk Management 2015, 11:185-193

Published Date: 3 March 2015

Review

Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms

Vacek TP, Rehman S, Neamtu D, Yu S, Givimani S, Tyagi SC

Vascular Health and Risk Management 2015, 11:173-183

Published Date: 27 February 2015

Original Research

Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control

Bays HE, Brinton EA, Triscari J, Chen E, Maccubbin D, MacLean AA, Gibson KL, Ruck RA, Johnson-Levonas AO, O’Neill EA, Mitchel YB

Vascular Health and Risk Management 2015, 11:165-172

Published Date: 24 February 2015

Review

Strokes in young adults: epidemiology and prevention

Smajlović D

Vascular Health and Risk Management 2015, 11:157-164

Published Date: 24 February 2015

Original Research

Effectiveness and tolerability of second-line treatment with vildagliptin versus other oral drugs for type 2 diabetes in a real-world setting in the Middle East: results from the EDGE study

Saab C, Al-Saber FA, Haddad J, Jallo MK, Steitieh H, Bader G, Ibrahim M

Vascular Health and Risk Management 2015, 11:149-155

Published Date: 24 February 2015

Review

Platelet function tests: a comparative review

Paniccia R, Priora R, Alessandrello Liotta A, Abbate R

Vascular Health and Risk Management 2015, 11:133-148

Published Date: 18 February 2015

Review

Sitagliptin/Simvastatin: a first combination tablet to treat type 2 diabetes and hypercholesterolemia – a review of its characteristics

Ramadan WH, Kabbara WK

Vascular Health and Risk Management 2015, 11:125-132

Published Date: 11 February 2015

Review

The role of factor Xa inhibitors in venous thromboembolism treatment

Cabral KP, Ansell JE

Vascular Health and Risk Management 2015, 11:117-123

Published Date: 30 January 2015

Review

Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes

Joseph JJ, Donner TW

Vascular Health and Risk Management 2015, 11:107-116

Published Date: 28 January 2015

Review

Prevention of stent thrombosis: challenges and solutions

Reejhsinghani R, Lotfi AS

Vascular Health and Risk Management 2015, 11:93-106

Published Date: 27 January 2015

Review

Scaffolds in vascular regeneration: current status

Thottappillil N, Nair PD

Vascular Health and Risk Management 2015, 11:79-91

Published Date: 19 January 2015

Original Research

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups

Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho BL, Ueng KC, DiTommaso S, Shete A

Vascular Health and Risk Management 2015, 11:71-78

Published Date: 21 January 2015

Review

Adiponectin as a potential biomarker of vascular disease

Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini SR, Fallah P, Bazi Z

Vascular Health and Risk Management 2015, 11:55-70

Published Date: 16 January 2015

Original Research

Validation of two automatic devices for the self-measurement of blood pressure according to the ANSI/AAMI/ISO81060-2:2009 guidelines: the Omron BP765 (HEM-7311-ZSA) and the Omron BP760N (HEM-7320-Z)

Takahashi H, Yoshika M, Yokoi T

Vascular Health and Risk Management 2015, 11:49-53

Published Date: 9 January 2015

Review

Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus

Beltrán LM, Rubio-Navarro A, Amaro-Villalobos JM, Egido J, García-Puig J, Moreno JA

Vascular Health and Risk Management 2015, 11:35-48

Published Date: 6 January 2015

Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both

Ghushchyan V, Nair KV, Page RL II

Vascular Health and Risk Management 2015, 11:25-34

Published Date: 24 December 2014

Review

Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease

Toth PP

Vascular Health and Risk Management 2015, 11:9-23

Published Date: 23 December 2014

Original Research

Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice

Bramlage P, Fronk EM, Wolf WP, Smolnik R, Sutton G, Schmieder RE

Vascular Health and Risk Management 2015, 11:1-8

Published Date: 17 December 2014

Original Research

Effects of exercise timing on sleep architecture and nocturnal blood pressure in prehypertensives

Fairbrother K, Cartner B, Alley JR, Curry CD, Dickinson DL, Morris DM, Collier SR

Vascular Health and Risk Management 2014, 10:691-698

Published Date: 12 December 2014

Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction

Claussen PA, Abdelnoor M, Kvakkestad KM, Eritsland J, Halvorsen S

Vascular Health and Risk Management 2014, 10:683-689

Published Date: 9 December 2014

Review

Complications of the endovascular management of acute ischemic stroke

Gill HL, Siracuse JJ, Parrack IK, Huang ZS, Meltzer AJ

Vascular Health and Risk Management 2014, 10:675-681

Published Date: 28 November 2014

Macitentan for the treatment of pulmonary arterial hypertension

Kholdani CA, Fares WH, Trow TK

Vascular Health and Risk Management 2014, 10:665-673

Published Date: 25 November 2014

Short Report

Changes in body weight after 24 weeks of vildagliptin therapy as a function of fasting glucose levels in patients with type 2 diabetes

Blüher M, Schweizer A, Bader G, Foley JE

Vascular Health and Risk Management 2014, 10:661-664

Published Date: 20 November 2014

Original Research

Uptitrating amlodipine significantly reduces blood pressure in diabetic patients with hypertension: a retrospective, pooled analysis

Jeffers BW, Bhambri R, Robbins J

Vascular Health and Risk Management 2014, 10:651-659

Published Date: 14 November 2014

N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes [Corrigendum]

Hamano K, Nakadaira I, Suzuki J, Gonai M

Vascular Health and Risk Management 2014, 10:649-650

Published Date: 13 November 2014

Original Research

A new coronary artery disease grading system correlates with numerous routine parameters that were associated with atherosclerosis: a grading system for coronary artery disease severity

Sponder M, Fritzer-Szekeres M, Marculescu R, Litschauer B, Strametz-Juranek J

Vascular Health and Risk Management 2014, 10:641-647

Published Date: 7 November 2014

Review

Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review

Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E

Vascular Health and Risk Management 2014, 10:627-639

Published Date: 7 November 2014

Review

Improving medication adherence in hypercholesterolemia: challenges and solutions

Gatwood J, Bailey JE

Vascular Health and Risk Management 2014, 10:615-625

Published Date: 6 November 2014

Case report

Congenital anomaly of the inferior vena cava and factor V Leiden mutation predisposing to deep vein thrombosis

Lamparello BM, Erickson CR, Kulthia A, Virparia V, Thet Z

Vascular Health and Risk Management 2014, 10:609-613

Published Date: 4 November 2014

Review

Optimal management of infrainguinal arterial occlusive disease

Pennywell DJ, Tan TW, Zhang WW

Vascular Health and Risk Management 2014, 10:599-608

Published Date: 24 October 2014

Original Research

Consumption of water containing over 3.5 mg of dissolved hydrogen could improve vascular endothelial function

Sakai T, Sato B, Hara K, Hara Y, Naritomi Y, Koyanagi S, Hara H, Nagao T, Ishibashi T

Vascular Health and Risk Management 2014, 10:591-597

Published Date: 17 October 2014

Original Research

N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes

Hamano K, Nakadaira I, Suzuki J, Gonai M

Vascular Health and Risk Management 2014, 10:585-589

Published Date: 3 October 2014

Review

Endothelial function testing and cardiovascular disease: focus on peripheral arterial tonometry

Bruno RM, Gori T, Ghiadoni L

Vascular Health and Risk Management 2014, 10:577-584

Published Date: 26 September 2014

Review

Economic and outcomes consequences of TachoSil®: a systematic review

Colombo GL, Bettoni D, Di Matteo S, Grumi C, Molon C, Spinelli D, Mauro G, Tarozzo A, Bruno GM

Vascular Health and Risk Management 2014, 10:569-576

Published Date: 10 September 2014

Sex differences in long-term outcomes of coronary patients treated with drug-eluting stents at a tertiary medical center

Shammas NW, Shammas GA, Jerin M, Sharis P

Vascular Health and Risk Management 2014, 10:563-568

Published Date: 9 September 2014

Original Research

Adding multiple risk factors improves Framingham coronary heart disease risk scores

Hu G, Root M, Duncan AW

Vascular Health and Risk Management 2014, 10:557-562

Published Date: 5 September 2014

Original Research

A three-dimensional electronic report of a venous echo color Doppler of the lower limbs: MEVeC®

Galeandro AI, Scicchitano P, Zito A, Galeandro C, Gesualdo M, Ciciarello F, Cecere A, Marzullo A, Contursi V, Annicchiarico A, Ciccone MM

Vascular Health and Risk Management 2014, 10:549-555

Published Date: 1 September 2014

Letter

Perindopril for improving cardiovascular events

DiNicolantonio JJ, O’Keefe JH

Vascular Health and Risk Management 2014, 10:539-548

Published Date: 30 August 2014

Original Research

Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women

Prasad M, Reriani M, Khosla S, Gössl M, Lennon R, Gulati R, Prasad A, Lerman LO, Lerman A

Vascular Health and Risk Management 2014, 10:533-538

Published Date: 26 August 2014

Original Research

Vasa vasorum anti-angiogenesis through H2O2, HIF-1α, NF-κB, and iNOS inhibition by mangosteen pericarp ethanolic extract (Garcinia mangostana Linn) in hypercholesterol-diet-given Rattus norvegicus Wistar strain

Wihastuti TA, Sargowo D, Tjokroprawiro A, Permatasari N, Widodo MA, Soeharto S

Vascular Health and Risk Management 2014, 10:523-531

Published Date: 21 August 2014

Review

A clinician’s perspective: novel oral anticoagulants to reduce the risk of stroke in nonvalvular atrial fibrillation – full speed ahead or proceed with caution?

Yang E

Vascular Health and Risk Management 2014, 10:507-522

Published Date: 21 August 2014

Review

Thoracoabdominal aortic aneurysm repair: current endovascular perspectives

Orr N, Minion D, Bobadilla JL

Vascular Health and Risk Management 2014, 10:493-505

Published Date: 19 August 2014

Review

Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials

Abdelnoor M, Sandven I, Limalanathan S, Eritsland J

Vascular Health and Risk Management 2014, 10:477-491

Published Date: 8 August 2014

Review

Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes

Dardano A, Bianchi C, Del Prato S, Miccoli R

Vascular Health and Risk Management 2014, 10:465-475

Published Date: 5 August 2014

Original Research

Heart rate variability measured early in patients with evolving acute coronary syndrome and 1-year outcomes of rehospitalization and mortality

Harris PR, Stein PK, Fung GL, Drew BJ

Vascular Health and Risk Management 2014, 10:451-464

Published Date: 5 August 2014

Original Research

Diagnostic accuracy of sensitive or high-sensitive troponin on presentation for myocardial infarction: a meta-analysis and systematic review

Sethi A, Bajaj A, Malhotra G, Arora RR, Khosla S

Vascular Health and Risk Management 2014, 10:435-450

Published Date: 21 July 2014

Study Protocol

XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation

Camm AJ, Amarenco P, Haas S, Hess S, Kirchhof P, Eickels MV, Turpie AGG

Vascular Health and Risk Management 2014, 10:425-434

Published Date: 17 July 2014

Review

Lower extremity amputation in peripheral artery disease: improving patient outcomes

Swaminathan A, Vemulapalli S, Patel MR, Jones WS

Vascular Health and Risk Management 2014, 10:417-424

Published Date: 16 July 2014

Review

Carotid revascularization: risks and benefits

O'Brien M, Chandra A

Vascular Health and Risk Management 2014, 10:403-416

Published Date: 7 July 2014

Cardiac angiosarcoma: utility of [18F]fluorodeoxyglucose positron emission tomography–computed tomography in evaluation of residue, metastases, and treatment response

Tokmak H, Demir N, Demirkol MO

Vascular Health and Risk Management 2014, 10:399-401

Published Date: 27 June 2014

Original Research

Effects of aliskiren- and ramipril-based treatment on central aortic blood pressure in elderly with systolic hypertension: a substudy of AGELESS

Baschiera F, Chang W, Brunel P

Vascular Health and Risk Management 2014, 10:389-397

Published Date: 25 June 2014

Original Research

Epidemiology of stroke in a rural community in Southeastern Nigeria

Enwereji KO, Nwosu MC, Ogunniyi A, Nwani PO, Asomugha AL, Enwereji EE

Vascular Health and Risk Management 2014, 10:375-388

Published Date: 24 June 2014

Review

Defining risks and predicting adverse events after lower extremity bypass for critical limb ischemia

Siracuse JJ, Huang ZS, Gill HL, Parrack I, Schneider DB, Connolly PH, Meltzer AJ

Vascular Health and Risk Management 2014, 10:367-374

Published Date: 23 June 2014

The triple line pattern on carotid intima media thickness imaging and its relationship to cardiovascular risk factors in patients on lipid lowering therapy

Singh TA, Villines TC, Taylor AJ

Vascular Health and Risk Management 2014, 10:363-366

Published Date: 20 June 2014

Review

Update on ranolazine in the management of angina

Codolosa JN, Acharjee S, Figueredo VM

Vascular Health and Risk Management 2014, 10:353-362

Published Date: 24 June 2014

Original Research

How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study

Penfornis A, Blicklé JF, Fiquet B, Quéré S, Dejager S

Vascular Health and Risk Management 2014, 10:341-352

Published Date: 13 June 2014

Original Research

Vascular quality of care pilot study: how admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease

Steenhof N, Le Piane F, Leblanc K, Eisenberg NR, Kwan Y, Malmberg C, Papadopoulos A, Roche-Nagle G

Vascular Health and Risk Management 2014, 10:333-340

Published Date: 4 June 2014

Original Research

Serum lipid profile and its association with hypertension in Bangladesh

Choudhury KN, Mainuddin AKM, Wahiduzzaman M, Islam SMS

Vascular Health and Risk Management 2014, 10:327-332

Published Date: 30 June 2014

Original Research

A double-blind, randomized trial, including frequent patient–physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study

Hassanein M, Abdallah K, Schweizer A

Vascular Health and Risk Management 2014, 10:319-326

Published Date: 28 May 2014

Original Research

Blood and urine levels of heavy metal pollutants in female and male patients with coronary artery disease

Sponder M, Fritzer-Szekeres M, Marculescu R, Mittlböck M, Uhl M, Köhler-Vallant B, Strametz-Juranek J

Vascular Health and Risk Management 2014, 10:311-317

Published Date: 13 May 2014

Original Research

Validation of the custo screen 400 ambulatory blood pressure-monitoring device according to the European Society of Hypertension International Protocol revision 2010

Bramlage P, Deutsch C, Krüger R, Wolf A, Müller P, Zwingers T, Beime B, Mengden T

Vascular Health and Risk Management 2014, 10:303-309

Published Date: 13 May 2014

Review

Rivaroxaban in patients with a recent acute coronary syndrome event: integration of trial findings into clinical practice

Shivu GN, Ossei-Gerning N

Vascular Health and Risk Management 2014, 10:291-302

Published Date: 12 May 2014

Original Research

Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia

Farnier M, Chen E, Johnson-Levonas AO, McCrary Sisk C, Mitchel YB

Vascular Health and Risk Management 2014, 10:279-290

Published Date: 7 May 2014

Original Research

Influence of serological factors and BMI on the blood pressure/hematocrit association in healthy young men and women

Salazar Vázquez BY, Salazar Vázquez MA, Chávez-Negrete A, Escobedo G, Cabrales P, Subramaniam S, Intaglietta M, Pérez-Tamayo R

Vascular Health and Risk Management 2014, 10:271-277

Published Date: 6 May 2014

Review

Inhibition of hepatic microsomal triglyceride transfer protein – a novel therapeutic option for treatment of homozygous familial hypercholesterolemia

Vuorio A, Tikkanen MJ, Kovanen PT

Vascular Health and Risk Management 2014, 10:263-270

Published Date: 6 May 2014

Original Research

Serum uric acid and target organ damage in essential hypertension

Ofori SN, Odia OJ

Vascular Health and Risk Management 2014, 10:253-261

Published Date: 2 May 2014

Original Research

The 24-hour pulse wave velocity, aortic augmentation index, and central blood pressure in normotensive volunteers

Kuznetsova TY, Korneva VA, Bryantseva EN, Barkan VS, Orlov AV, Posokhov IN, Rogoza AN

Vascular Health and Risk Management 2014, 10:247-251

Published Date: 28 April 2014

Original Research

Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

Marrett E, Zhao C, Zhang NJ, Zhang Q, Ramey DR, Tomassini JE, Tershakovec AM, Neff DR

Vascular Health and Risk Management 2014, 10:237-246

Published Date: 25 April 2014

Original Research

Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study

Azar ST, Hantash HA, Jambart S, El-Zaheri MM, Rachoin R, Chalfoun A, Lahoud L, Okkeh O, Bramlage P, Brudi P, Ambegaonkar BM

Vascular Health and Risk Management 2014, 10:225-235

Published Date: 7 May 2014

Review

Telemonitoring: use in the management of hypertension

Sivakumaran D, Earle KA

Vascular Health and Risk Management 2014, 10:217-224

Published Date: 10 April 2014

Review

Current guidelines for high-density lipoprotein cholesterol in therapy and future directions

Subedi BH, Joshi PH, Jones SR, Martin SS, Blaha MJ, Michos ED

Vascular Health and Risk Management 2014, 10:205-216

Published Date: 8 April 2014

Mini-review

Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations

Jovanovic A, Stolic RV, Rasic DV, Markovic-Jovanovic SR, Peric VM

Vascular Health and Risk Management 2014, 10:201-204

Published Date: 8 April 2014

Review

Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril

Wang JG, Pimenta E, Chwallek F

Vascular Health and Risk Management 2014, 10:189-200

Published Date: 5 April 2014

Review

Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar

Cho JR, Rollini F, Franchi F, Ferrante E, Angiolillo DJ

Vascular Health and Risk Management 2014, 10:177-188

Published Date: 3 April 2014

Review

Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa

Isaacson SH, Skettini J

Vascular Health and Risk Management 2014, 10:169-176

Published Date: 3 April 2014

Original Research

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty

Levitan B, Yuan Z, Turpie AGG, Friedman RJ, Homering M, Berlin JA, Berkowitz SD, Weinstein RB, DiBattiste PM

Vascular Health and Risk Management 2014, 10:157-167

Published Date: 26 March 2014

Original Research

Reduction in cardiovascular risk using a proactive multifactorial intervention is consistent among patients residing in Pacific Asian and non-Pacific Asian regions: a CRUCIAL trial subanalysis

Cho EJ, Kim JH, Sutradhar S, Yunis C, Westergaard M

Vascular Health and Risk Management 2014, 10:145-156

Published Date: 26 March 2014

Original Research

The "Pulse Time Index of Norm" highly correlates with the left ventricular mass index in patients with arterial hypertension

Posokhov IN, Kulikova NN, Starchenkova IV, Grigoricheva EA, Evdokimov VV, Orlov AV, Rogoza AN

Vascular Health and Risk Management 2014, 10:139-144

Published Date: 19 March 2014

Association of hypertension and obesity with HIV and antiretroviral therapy in a rural tertiary health center in Nigeria: a cross-sectional cohort study

Ogunmola OJ, Oladosu OY, Olamoyegun AM

Vascular Health and Risk Management 2014, 10:129-137

Published Date: 18 March 2014

Review

Challenges associated with peripheral arterial disease in women

Barochiner J, Aparicio LS, Waisman GD

Vascular Health and Risk Management 2014, 10:115-128

Published Date: 10 March 2014

Review

Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk

Haas S, Bode C, Norrving B, Turpie AGG

Vascular Health and Risk Management 2014, 10:101-114

Published Date: 10 March 2014

Original Research

Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation

Evans M, Rumberger JA, Azumano I, Napolitano JJ, Citrolo D, Kamiya T

Vascular Health and Risk Management 2014, 10:89-100

Published Date: 27 February 2014

Review

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke

Chapman SN, Mehndiratta P, Johansen MC, McMurry TL, Johnston KC, Southerland AM

Vascular Health and Risk Management 2014, 10:75-87

Published Date: 24 February 2014

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey

Petrella RJ, Tremblay G, De Backer G, Gill DP

Vascular Health and Risk Management 2014, 10:63-74

Published Date: 29 January 2014

Original Research

Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C – a cross-sectional study

Roed T, Kristoffersen US, Knudsen A, Wiinberg N, Lebech AM, Almdal T, Thomsen RW, Kjær A, Weis N

Vascular Health and Risk Management 2014, 10:55-62

Published Date: 21 January 2014

Original Research

Is higher body temperature beneficial in ischemic stroke patients with normal admission CT angiography of the cerebral arteries?

Kvistad CE, Khanevski A, Nacu A, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2014, 10:49-54

Published Date: 21 January 2014

Letter

Dabigatran and myocardial infarction: a foggy scenario

Pontillo D, Patruno N

Vascular Health and Risk Management 2014, 10:45-48

Published Date: 20 January 2014

Original Research

Validation of four devices: Omron M6 Comfort, Omron HEM-7420, Withings BP-800, and Polygreen KP-7670 for home blood pressure measurement according to the European Society of Hypertension International Protocol

Topouchian J, Agnoletti D, Blacher J, Youssef A, Chahine MN, Ibanez I, Assemani N, Asmar R

Vascular Health and Risk Management 2014, 10:33-44

Published Date: 16 January 2014

Review

Risk of stroke associated with nonsteroidal anti-inflammatory drugs

Park K, Bavry AA

Vascular Health and Risk Management 2014, 10:25-32

Published Date: 6 January 2014

Review

Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan

Schweizer A, Halimi S, Dejager S

Vascular Health and Risk Management 2014, 10:15-24

Published Date: 24 December 2013

Letter

Accurate use of neutrophil/lymphocyte ratio from the perspective of laboratory experts

Sertoglu E, Uyanik M

Vascular Health and Risk Management 2014, 10:13-14

Published Date: 20 December 2013

Review

Avoiding permanent atrial fibrillation: treatment approaches to prevent disease progression

Shukla A, Curtis AB

Vascular Health and Risk Management 2014, 10:1-12

Published Date: 16 December 2013

Original Research

Serum lipid profile and correlates in newly presenting Nigerians with arterial hypertension

Adamu UG, Okuku GA, Oladele CO, Abdullahi A, Oduh JI, Fasae AJ

Vascular Health and Risk Management 2013, 9:763-768

Published Date: 3 December 2013

Original Research

Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients

Daud ZAM, Tubie B, Sheyman M, Osia R, Adams J, Tubie S, Khosla P

Vascular Health and Risk Management 2013, 9:747-761

Published Date: 28 November 2013

Original Research

Visceral obesity is not an independent risk factor of mortality in subjects over 65 years

Thomas F, Pannier B, Benetos A, Vischer UM

Vascular Health and Risk Management 2013, 9:739-745

Published Date: 22 November 2013

Original Research

Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk

Lai H, Fishman EK, Gerstenblith G, Moore R, Brinker JA, Keruly JC, Chen S, Detrick B, Lai S

Vascular Health and Risk Management 2013, 9:729-737

Published Date: 15 November 2013

Original Research

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy

Foody JM, Toth PP, Tomassini JE, Sajjan S, Ramey DR, Neff D, Tershakovec AM, Hu H, Tunceli K

Vascular Health and Risk Management 2013, 9:719-727

Published Date: 15 November 2013

Original Research

Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study

Seufert J, Pegelow K, Bramlage P

Vascular Health and Risk Management 2013, 9:711-717

Published Date: 13 November 2013

Original Research

Lipid profiles and inflammatory markers after periodontal treatment in children with congenital heart disease and at risk for atherosclerosis

Bresolin AC, Pronsatti MM, Pasqualotto LN, Nassar PO, Jorge AS, Silva EA, Nassar CA

Vascular Health and Risk Management 2013, 9:703-709

Published Date: 11 November 2013

Original Research

Titration of amlodipine to higher doses: a comparison of Asian and Western experience

Kario K, Robbins J, Jeffers BW

Vascular Health and Risk Management 2013, 9:695-701

Published Date: 5 November 2013

Review

Linagliptin as add-on therapy to insulin for patients with type 2 diabetes

von Websky K, Reichetzeder C, Hocher B

Vascular Health and Risk Management 2013, 9:681-694

Published Date: 1 November 2013

Original Research

Association between triglycerides and cardiovascular events in primary populations: a meta-regression analysis and synthesis of evidence

Stauffer ME, Weisenfluh L, Morrison A

Vascular Health and Risk Management 2013, 9:671-680

Published Date: 31 October 2013

Review

Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes

Kones R

Vascular Health and Risk Management 2013, 9:617-670

Published Date: 21 October 2013

Original Research

Cardiovascular outcomes during treatment with dabigatran: comprehensive analysis of individual subject data by treatment

Clemens A, Fraessdorf M, Friedman J

Vascular Health and Risk Management 2013, 9:599-615

Published Date: 11 October 2013

Original Research

Postmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery

Kuroda Y, Hirayama C, Hotoda H, Nishikawa Y, Nishiwaki A

Vascular Health and Risk Management 2013, 9:593-598

Published Date: 7 October 2013

Review

Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan

Gialama F, Maniadakis N

Vascular Health and Risk Management 2013, 9:575-592

Published Date: 7 October 2013

Original Research

Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study

Offman E, Marenco T, Ferber S, Johnson J, Kling D, Curcio D, Davidson M

Vascular Health and Risk Management 2013, 9:563-573

Published Date: 1 October 2013

Lifetime opiate exposure as an independent and interactive cardiovascular risk factor in males: a cross-sectional clinical study

Reece AS, Hulse GK

Vascular Health and Risk Management 2013, 9:551-561

Published Date: 2 October 2013

Original Research

Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial

Radchenko GD, Sirenko YM, Kushnir SM, Torbas OO, Dobrokhod AS

Vascular Health and Risk Management 2013, 9:535-549

Published Date: 27 September 2013

Original Research

Left ventricular dysfunction in normotensive type II diabetic patients in Port Harcourt, Nigeria

Dodiyi-Manuel ST, Akpa MR, Odia OJ

Vascular Health and Risk Management 2013, 9:529-533

Published Date: 25 September 2013

Review

A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide

Segura J, Ruilope LM

Vascular Health and Risk Management 2013, 9:521-528

Published Date: 16 September 2013

Short Report

Serum calcium levels are not associated with coronary heart disease

Jin Y, He L, Wang Q, Chen Y, Ren X, Tang H, Song X, Ding L, Qi Q, Huang Z, Yu J, Yao Y

Vascular Health and Risk Management 2013, 9:517-520

Published Date: 3 September 2013

Original Research

Increased burden and severity of metabolic syndrome and arterial stiffness in treatment naïve HIV+ patients from Cameroon

Ngatchou W, Lemogoum D, Ndobo P, Yagnigni E, Tiogou E, Nga E, Kouanfack C, van de Borne P, Hermans MP

Vascular Health and Risk Management 2013, 9:509-516

Published Date: 4 September 2013

Original Research

Spanish translation, cross-cultural adaptation, and validation of the Questionnaire for Diabetes-Related Foot Disease (Q-DFD)

Castillo-Tandazo W, Flores-Fortty A, Feraud L, Tettamanti D

Vascular Health and Risk Management 2013, 9:501-508

Published Date: 28 August 2013

Original Research

Vitamin D deficiency is associated with coronary artery calcification in cardiovascularly asymptomatic African Americans with HIV infection

Lai S, Fishman EK, Gerstenblith G, Brinker J, Tai H, Chen S, Li J, Tong W, Detrick B, Lai H

Vascular Health and Risk Management 2013, 9:493-500

Published Date: 26 August 2013

Original Research

Perceptions of barriers to cardiac rehabilitation use in Brazil

Ghisi GLM, Santos RZ, Aranha EE, Nunes AD, Oh P, Benetti M, Grace SL

Vascular Health and Risk Management 2013, 9:485-491

Published Date: 30 August 2013

Original Research

Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice

Bramlage P, Zemmrich C, Ketelhut R, Wolf WP, Fronk EM, Schmieder RE

Vascular Health and Risk Management 2013, 9:475-483

Published Date: 26 August 2013

Original Research

Prognostic value of heart rate turbulence for risk assessment in patients with unstable angina and non-ST elevation myocardial infarction

Harris PRE, Stein PK, Fung GL, Drew BJ

Vascular Health and Risk Management 2013, 9:465-473

Published Date: 12 August 2013

Original Research

Vacuum-venipuncture skills: time required and importance of tube order

Fujii C

Vascular Health and Risk Management 2013, 9:457-464

Published Date: 5 August 2013

Review

Emerging families of biomarkers for coronary artery disease: inflammatory mediators

Yayan J

Vascular Health and Risk Management 2013, 9:435-456

Published Date: 31 July 2013

Review

Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk

Zou C, Hu H

Vascular Health and Risk Management 2013, 9:429-433

Published Date: 25 July 2013

Review

Current status of NADPH oxidase research in cardiovascular pharmacology

Rodiño-Janeiro BK, Paradela-Dobarro B, Castiñeiras-Landeira MI, Raposeiras-Roubín S, González-Juanatey JR, Álvarez E

Vascular Health and Risk Management 2013, 9:401-428

Published Date: 25 July 2013

Original Research

The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report

Ferrario CM, Joyner J, Colby C, Exuzides A, Moore M, Simmons D, Bestermann Jr W, Frech-Tamas F

Vascular Health and Risk Management 2013, 9:391-400

Published Date: 22 July 2013

Short Report

Clarification of the characteristics of needle-tip movement during vacuum venipuncture to improve safety

Fujii C

Vascular Health and Risk Management 2013, 9:381-390

Published Date: 23 July 2013

Original Research

Effects of low-fat dairy intake on blood pressure, endothelial function, and lipoprotein lipids in subjects with prehypertension or stage 1 hypertension

Maki KC, Rains TM, Schild AL, Dicklin MR, Park KM, Lawless AL, Kelley KM

Vascular Health and Risk Management 2013, 9:369-379

Published Date: 23 July 2013

Original Research

Neutrophil/lymphocyte ratio in patients with atrial septal aneurysm

Demir M, Demir C

Vascular Health and Risk Management 2013, 9:365-368

Published Date: 19 July 2013

Original Research

Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study

Saifan C, El-Charabaty E, El-Sayegh S

Vascular Health and Risk Management 2013, 9:361-364

Published Date: 17 July 2013

Review

Review and recommendations on management of refractory raised intracranial pressure in aneurysmal subarachnoid hemorrhage

Mak CH, Lu YY, Wong GK

Vascular Health and Risk Management 2013, 9:353-359

Published Date: 11 July 2013

Review

The clinical efficacy of dabigatran etexilate for preventing stroke in atrial fibrillation patients

Ellis CR, Kaiser DW

Vascular Health and Risk Management 2013, 9:341-352

Published Date: 9 July 2013

Original Research

Pattern of sudden death at Ladoke Akintola University of Technology Teaching Hospital, Osogbo, South West Nigeria

Akinwusi PO, Komolafe AO, Olayemi OO, Adeomi AA

Vascular Health and Risk Management 2013, 9:333-339

Published Date: 24 June 2013

Review

Aldosterone receptor antagonists: current perspectives and therapies

Guichard JL, Clark III D, Calhoun DA, Ahmed MI

Vascular Health and Risk Management 2013, 9:321-331

Published Date: 24 June 2013

Review

Statins in heart failure: do we need another trial?

Bonsu KO, Kadirvelu A, Reidpath DD

Vascular Health and Risk Management 2013, 9:303-319

Published Date: 17 June 2013

Original Research

Persistent middle cerebral artery occlusion associated with lower body temperature on admission

Kvistad CE, Øygarden H, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2013, 9:297-302

Published Date: 17 June 2013

Original Research

Evaluation of vascular wall elasticity of human digital arteries using alternating current-signal photoplethysmography

Uangpairoj P, Shibata M

Vascular Health and Risk Management 2013, 9:283-295

Published Date: 5 June 2013

Review

Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin

Steinberg H, Anderson MS, Musliner T, Hanson ME, Engel SS

Vascular Health and Risk Management 2013, 9:273-282

Published Date: 29 May 2013

Methodology

Validation of Omron RS8, RS6, and RS3 home blood pressure monitoring devices, in accordance with the European Society of Hypertension International Protocol revision 2010

Takahashi H, Yoshika M, Yokoi T

Vascular Health and Risk Management 2013, 9:265-272

Published Date: 28 May 2013

Review

Current and future initiatives for vascular health management in clinical practice

Cameron JD, Asmar R, Struijker-Boudier H, Shirai K, Sirenko Y, Kotovskaya Y, Topouchian J

Vascular Health and Risk Management 2013, 9:255-264

Published Date: 28 May 2013

Review

Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events

Sylvester KW, Cheng JW, Mehra MR

Vascular Health and Risk Management 2013, 9:245-254

Published Date: 16 May 2013

Original Research

Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus

Wang ZS, Song ZC, Bai JH, Li F, Wu T, Qi J, Hu J

Vascular Health and Risk Management 2013, 9:237-243

Published Date: 14 May 2013

Original Research

Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension

Litvin AY, Sukmarova ZN, Elfimova EM, Aksenova AV, Galitsin PV, Rogoza AN, Chazova IE

Vascular Health and Risk Management 2013, 9:229-235

Published Date: 10 May 2013

Review

Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients

Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E, Rocha E

Vascular Health and Risk Management 2013, 9:207-228

Published Date: 8 May 2013

Review

Endoglin: a critical mediator of cardiovascular health

Kapur NK, Morine KJ, Letarte M

Vascular Health and Risk Management 2013, 9:195-206

Published Date: 6 May 2013

Original Research

Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department

Sharma RK, Erickson SW, Sharma R, Voelker DJ, Reddy HK, Dod H, Marsh JD

Vascular Health and Risk Management 2013, 9:187-193

Published Date: 1 May 2013

Original Research

Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign

Omboni S, Carabelli G, Ghirardi E, Carugo S

Vascular Health and Risk Management 2013, 9:177-185

Published Date: 30 April 2013

Review

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update

Tsuji Y, Dobrev D

Vascular Health and Risk Management 2013, 9:165-175

Published Date: 23 April 2013

Review

Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes

Ahrén B

Vascular Health and Risk Management 2013, 9:155-163

Published Date: 24 April 2013

Review

Stress-induced cardiomyopathy (Takotsubo) – broken heart and mind?

Redfors B, Shao Y, Omerovic E

Vascular Health and Risk Management 2013, 9:149-154

Published Date: 17 April 2013

Original Research

Short-term outcome of patients with preeclampsia

Koual M, Abbou H, Carbonnel M, Picone O, Ayoubi JM

Vascular Health and Risk Management 2013, 9:143-148

Published Date: 15 April 2013

Review

Long-term safety and efficacy of endovascular abdominal aortic aneurysm repair

Propper BW, Abularrage CJ

Vascular Health and Risk Management 2013, 9:135-141

Published Date: 3 April 2013

Review

Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently?

Mahabala C, Kamath P, Bhaskaran U, Pai ND, Pai AU

Vascular Health and Risk Management 2013, 9:125-133

Published Date: 24 March 2013

Original Research

Hydrogen sulfide and sodium nitroprusside compete to activate/deactivate MMPs in bone tissue homogenates

Vacek TP, Qipshidze N, Tyagi SC

Vascular Health and Risk Management 2013, 9:117-123

Published Date: 19 March 2013

Review

The influence of perivascular adipose tissue on vascular homeostasis

Szasz T, Bomfim GF, Webb RC

Vascular Health and Risk Management 2013, 9:105-116

Published Date: 28 March 2013

Review

Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension

Billecke SS, Marcovitz PA

Vascular Health and Risk Management 2013, 9:95-104

Published Date: 16 March 2013

Original Research

Comparison between oscillometric- and Doppler-ABI in elderly individuals

Takahashi I, Furukawa K, Ohishi W, Takahashi T, Matsumoto M, Fujiwara S

Vascular Health and Risk Management 2013, 9:89-94

Published Date: 8 March 2013

Original Research

Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance

El-Helou N, Al-Hajje A, Ajrouche R, Awada S, Rachidi S, Zein S, Salameh P

Vascular Health and Risk Management 2013, 9:81-88

Published Date: 1 March 2013

Original Research

Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry

Schaefer JR, Gitt AK, Sonntag F, Weizel A, Jannowitz C, Karmann B, Pittrow D, Bestehorn K

Vascular Health and Risk Management 2013, 9:71-80

Published Date: 21 February 2013

Original Research

Comparative effect of clopidogrel plus aspirin and aspirin monotherapy on hematological parameters using propensity score matching

Hayasaka M, Takahashi Y, Nishida Y, Yoshida Y, Hidaka S, Asai S

Vascular Health and Risk Management 2013, 9:65-70

Published Date: 18 February 2013

Review

Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

Schweizer A, Foley JE, Kothny W, Ahrén B

Vascular Health and Risk Management 2013, 9:57-64

Published Date: 15 February 2013

Original Research

Cardioprotective medication use and risk factor control among US adults with unrecognized myocardial infarction: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study

Levitan EB, Gamboa C, Safford MM, Rizk DV, Brown TM, Soliman EZ, Muntner P

Vascular Health and Risk Management 2013, 9:47-55

Published Date: 5 February 2013

Review

Metabolic biomarkers for predicting cardiovascular disease

Montgomery JE, Brown JR

Vascular Health and Risk Management 2013, 9:37-45

Published Date: 29 January 2013

Original Research

Heel-rise test in the assessment of individuals with peripheral arterial occlusive disease

Monteiro DP, Britto RR, Lages AC, Basílio ML, Pires MC, Carvalho ML, Procópio RJ, Pereira DA

Vascular Health and Risk Management 2013, 9:29-35

Published Date: 23 January 2013

Original Research

Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment

Lukashevich V, Schweizer A, Foley JE, Dickinson S, Groop PH, Kothny W

Vascular Health and Risk Management 2013, 9:21-28

Published Date: 23 January 2013

Original Research

Effectiveness of a quality improvement intervention targeting cardiovascular risk factors: are patients responsive to information and encouragement by mail or post?

Senesael E, Borgermans L, Van De Vijver E, Devroey D

Vascular Health and Risk Management 2013, 9:13-20

Published Date: 13 February 2013

Review

Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence

Ferguson C, Inglis SC, Newton PJ, Middleton S, Macdonald PS, Davidson PM

Vascular Health and Risk Management 2013, 9:3-11

Published Date: 17 January 2013

Corrigendum

Corrigendum

Basit A, Riaz M, Fawwad A

Vascular Health and Risk Management 2013, 9:1-2

Published Date: 27 December 2012

Letter

ESR rate can be a marker for coronary artery disease

Eghbal Eftekhaari T

Vascular Health and Risk Management 2012, 8:669-670

Published Date: 18 December 2012

Original Research

Microencapsulated conjugated linoleic acid associated with hypocaloric diet reduces body fat in sedentary women with metabolic syndrome

Carvalho RF, Uehara SK, Rosa G

Vascular Health and Risk Management 2012, 8:661-667

Published Date: 13 December 2012

Review

Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia

Bell DA, Hooper AJ, Watts GF, Burnett JR

Vascular Health and Risk Management 2012, 8:651-659

Published Date: 28 November 2012

Original Research

Diagnosis of carotid artery stenosis with oculopneumoplethysmography alone and in combination with MRA

Elias RM, Wald JT, Kallmes DF

Vascular Health and Risk Management 2012, 8:631-639

Published Date: 23 November 2012

Original Research

Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers

Chiquette E, Toth PP, Ramirez G, Cobble M, Chilton R

Vascular Health and Risk Management 2012, 8:621-629

Published Date: 12 November 2012

Review

Treatment of prehypertension: lifestyle and/or medication

Collier SR, Landram MJ

Vascular Health and Risk Management 2012, 8:613-619

Published Date: 15 November 2012

Original Research

Cerebral blood flow in Alzheimer’s disease

Roher AE, Debbins JP, Malek-Ahmadi M, Chen K, Pipe JG, Maze S, Belden C, Maarouf CL, Thiyyagura P, Mo H, Hunter JM, Kokjohn TA, Walker DG, Kruchowsky JC, Belohlavek M, Sabbagh MN, Beach TG

Vascular Health and Risk Management 2012, 8:599-611

Published Date: 23 October 2012

Original Research

Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices

Ewen E, Zhang Z, Simon TA, Kolm P, Liu X, Weintraub WS

Vascular Health and Risk Management 2012, 8:587-598

Published Date: 19 October 2012

Original Research

Prevalence and risk factors associated with peripheral artery disease in elderly patients undergoing peritoneal dialysis

Kuang DW, Li CL, Kuok UI, Cheung K, Lio WI, Xin J

Vascular Health and Risk Management 2012, 8:581-586

Published Date: 19 October 2012

Review

The potential benefit of stem cell therapy after stroke: an update

Banerjee S, Williamson DA, Habib N, Chataway J

Vascular Health and Risk Management 2012, 8:569-580

Published Date: 10 October 2012

Rapid Communication

Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the observational POWER study

Goudev A, Berrou J-P, Pathak A

Vascular Health and Risk Management 2012, 8:563-568

Published Date: 25 September 2012

Review

The prevention and regression of atherosclerotic plaques: emerging treatments

Kalanuria AA, Nyquist P, Ling G

Vascular Health and Risk Management 2012, 8:549-561

Published Date: 25 September 2012

Original Research

Diabetes prevalence and metabolic risk profile in an unselected population visiting pharmacies in Switzerland

Rey A, Thoenes M, Fimmers R, Meier CA, Bramlage P

Vascular Health and Risk Management 2012, 8:541-547

Published Date: 21 September 2012

Review

The complex regulation of TGF-ß in cardiovascular disease

Redondo S, Navarro-Dorado J, Ramajo M, Medina Ú, Tejerina T

Vascular Health and Risk Management 2012, 8:533-539

Published Date: 13 September 2012

Review

Rivaroxaban in atrial fibrillation

Giorgi MA, Miguel LS

Vascular Health and Risk Management 2012, 8:525-531

Published Date: 30 August 2012

Review

Avanafil for treatment of erectile dysfunction: review of its potential

Burke RM, Evans JD

Vascular Health and Risk Management 2012, 8:517-523

Published Date: 29 August 2012

Original Research

Ethnicity and acute myocardial infarction: risk profile at presentation, access to hospital management, and outcome in Norway

Abdelnoor M, Eritsland J, Brunborg C, Halvorsen S

Vascular Health and Risk Management 2012, 8:505-515

Published Date: 24 August 2012

Perspectives

The ClaudicatioNet concept: design of a national integrated care network providing active and healthy aging for patients with intermittent claudication

Lauret GJ, Gijsbers HJ, Hendriks EJ, Bartelink ML, de Bie RA, Teijink JA

Vascular Health and Risk Management 2012, 8:495-503

Published Date: 24 August 2012

Review

Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib

Miyares MA, Davis K

Vascular Health and Risk Management 2012, 8:483-493

Published Date: 23 August 2012

Original Research

Disparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patients

Reibis R, Treszl A, Wegscheider K, Bestehorn K, Karmann B, Voeller H

Vascular Health and Risk Management 2012, 8:473-481

Published Date: 17 August 2012

Review

Glimepiride: evidence-based facts, trends, and observations

Basit A, Riaz M, Fawwad A

Vascular Health and Risk Management 2012, 8:463-472

Published Date: 15 August 2012

Original Research

Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans

Longo-Mbenza B, Nsenga JN, Mokondjimobe E, Gombet T, Assori IN, Ibara JR, Ellenga-Mbolla B, Vangu DN, Fuele SM

Vascular Health and Risk Management 2012, 8:455-461

Published Date: 15 August 2012

Original Research

Endotoxin-induced and vaccine-induced systemic inflammation both impair endothelium-dependent vasodilation, but not pulse wave reflection

Lind L, Hulthe J, Johansson A, Hedner E

Vascular Health and Risk Management 2012, 8:447-453

Published Date: 24 July 2012

Corrigendum

Corrigendum

De Caterina AR, Harper AR, Cuculi F

Vascular Health and Risk Management 2012, 8:443-445

Published Date: 19 July 2012

Review

Proof of concept in cardiovascular risk: the paradoxical findings in blood pressure and lipid abnormalities

Fuchs FD, Fuchs SC, Moreira LB, Gus M

Vascular Health and Risk Management 2012, 8:437-442

Published Date: 12 July 2012

Review

Treatment strategy for type 2 diabetes from the perspective of systemic vascular protection and insulin resistance

Utsunomiya K

Vascular Health and Risk Management 2012, 8:429-436

Published Date: 4 July 2012

Review

Ezetimibe therapy: mechanism of action and clinical update

Phan BAP, Dayspring TD, Toth PP

Vascular Health and Risk Management 2012, 8:415-427

Published Date: 3 July 2012

Original Research

The effects of fatigue, pain, and depression on quality of life in ischemic stroke patients: The Bergen Stroke Study

Naess H, Lunde L, Brogger J

Vascular Health and Risk Management 2012, 8:407-413

Published Date: 27 June 2012

Review

Everolimus-eluting stents in interventional cardiology

Townsend JC, Rideout P, Steinberg DH

Vascular Health and Risk Management 2012, 8:393-405

Published Date: 27 June 2012

Case report

Lift the quilt in case of atrial fibrillation and disc prolapse

Bastovansky A, Ziegler K, Stöllberger C, Finsterer J

Vascular Health and Risk Management 2012, 8:389-392

Published Date: 22 June 2012

Review

Clinical utility of azilsartan–chlorthalidone fixed combination in the management of hypertension

Shuster JE, Bleske BE, Dorsch MP

Vascular Health and Risk Management 2012, 8:381-387

Published Date: 13 June 2012

Original Research

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic

Volpe M, Tocci G

Vascular Health and Risk Management 2012, 8:371-380

Published Date: 11 June 2012

Methodology

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery

Turpie AG, Schmidt AC, Kreutz R, Lassen MR, Jamal W, Mantovani L, Haas S

Vascular Health and Risk Management 2012, 8:363-370

Published Date: 1 June 2012

Review

Very low levels of HDL cholesterol and atherosclerosis, a variable relationship – a review of LCAT deficiency

Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T

Vascular Health and Risk Management 2012, 8:357-361

Published Date: 5 June 2012

Original Research

Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action

Al-Omran M

Vascular Health and Risk Management 2012, 8:349-355

Published Date: 28 May 2012

Review

Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus

Dejager S, Schweizer A, Foley JE

Vascular Health and Risk Management 2012, 8:339-348

Published Date: 18 May 2012

Original Research

Low body temperature associated with severe ischemic stroke within 6 hours of onset: The Bergen NORSTROKE Study

Kvistad CE, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2012, 8:333-338

Published Date: 1 June 2012

Review

Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases

Shinkai H

Vascular Health and Risk Management 2012, 8:323-331

Published Date: 15 May 2012

Review

Use of carvedilol in hypertension: an update

Leonetti G, Egan CG

Vascular Health and Risk Management 2012, 8:307-322

Published Date: 18 May 2012

Review

Critical evaluation of the efficacy and tolerability of azilsartan

De Caterina AR, Harper AR, Cuculi F

Vascular Health and Risk Management 2012, 8:299-305

Published Date: 14 May 2012

Original Research

Smoking status and sex as indicators of differences in 2582 obese patients presenting for weight management

Abunassar MJ, Wells GA, Dent RR

Vascular Health and Risk Management 2012, 8:291-298

Published Date: 7 May 2012

Original Research

Percutaneous mechanical thrombectomy for treatment of acute femoropopliteal bypass occlusion

Lichtenberg M, Käunicke M, Hailer B

Vascular Health and Risk Management 2012, 8:283-289

Published Date: 4 May 2012

Original Research

Lack of a relationship between circulating gamma-glutamyltransferase levels and carotid intima media thickness in hypertensive and diabetic patients

Nuti M, Spontoni P, Grigoratos C, Dell'Omo G, Balbarini A, Pedrinelli R

Vascular Health and Risk Management 2012, 8:275-281

Published Date: 1 May 2012

Original Research

Treatment patterns and risk factor control in patients with and without metabolic syndrome in cardiac rehabilitation

Gitt A, Jannowitz C, Karoff M, Karmann B, Horack M, Völler H

Vascular Health and Risk Management 2012, 8:265-274

Published Date: 24 April 2012

Original Research

Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis

Gaebler JA, Soto-Campos G, Alperin P, Cohen M, Blickensderfer A, Wintle M, Maggs D, Hoogwerf B, Han J, Pencek R, Peskin B

Vascular Health and Risk Management 2012, 8:255-264

Published Date: 23 April 2012

Original Research

Mixed dyslipidemias in primary care patients in France

Laforest L, Ambegaonkar BM, Souchet T, Sazonov V, Van Ganse E

Vascular Health and Risk Management 2012, 8:247-254

Published Date: 19 April 2012

Original Research

Accuracy of the ankle-brachial index using the SCVL®, an arm and ankle automated device with synchronized cuffs, in a population with increased cardiovascular risk

Rosenbaum D, Rodriguez-Carranza S, Laroche P, Bruckert E, Giral P, Girerd X

Vascular Health and Risk Management 2012, 8:239-246

Published Date: 17 April 2012

Original Research

The predictive power of depression screening procedures for veterans with coronary artery disease

Shankman SA, Nadelson J, McGowan SK, Sovari AA, Vidovich MI

Vascular Health and Risk Management 2012, 8:233-238

Published Date: 17 April 2012

Original Research

Effects of a 6-month exercise program pilot study on walking economy, peak physiological characteristics, and walking performance in patients with peripheral arterial disease

Crowther RG, Leicht AS, Spinks WL, Sangla K, Quigley F, Golledge J

Vascular Health and Risk Management 2012, 8:225-232

Published Date: 17 April 2012

Original Research

Erythrocyte sedimentation rate as a marker for coronary heart disease

Yayan J

Vascular Health and Risk Management 2012, 8:219-223

Published Date: 11 April 2012

Original Research

Correlation of natriuretic peptides and inferior vena cava size in patients with congestive heart failure

Hebl V, Zakharova MY, Canoniero M, Duprez D, Garcia S

Vascular Health and Risk Management 2012, 8:213-218

Published Date: 10 April 2012

Original Research

Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center

Shammas NW, Shammas GA , Nader E, Jerin M, Mrad L, Marogil P, Henn C, Dvorak A, Chintalapani A, Meriner S

Vascular Health and Risk Management 2012, 8:205-211

Published Date: 11 April 2012

Original Research

Hemocompatibility of stent materials: alterations in electrical parameters of erythrocyte membranes

Basoli A, Cametti C, Ginnari Satriani F, Mariani P, Severino P

Vascular Health and Risk Management 2012, 8:197-204

Published Date: 21 March 2012

Original Research

Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients

Mat Daud ZA, Tubie B, Adams J, Quainton T, Osia R, Tubie S, Kaur D, Khosla P, Sheyman M

Vascular Health and Risk Management 2012, 8:187-195

Published Date: 20 March 2012

Original Research

Barriers to cardiovascular risk prevention and management in Germany – an analysis of the EURIKA study

Schmieder RE, Goebel M, Bramlage P

Vascular Health and Risk Management 2012, 8:177-186

Published Date: 15 March 2012

Original Research

Major risk factors for the appearance of white-matter lesions on MRI in hypertensive patients with controlled blood pressure

Takami T, Yamano S, Okada S, Sakuma M, Morimoto T, Hashimoto H, Somekawa S, Saito Y

Vascular Health and Risk Management 2012, 8:169-176

Published Date: 14 March 2012

Original Research

Lower extremity venous thrombosis in patients younger than 50 years of age

Kreidy R, Salameh P, Waked M

Vascular Health and Risk Management 2012, 8:161-167

Published Date: 13 March 2012

Review

Nebivolol: impact on cardiac and endothelial function and clinical utility

Toblli JE, DiGennaro F, Giani JF, Dominici FP

Vascular Health and Risk Management 2012, 8:151-160

Published Date: 13 March 2012

Review

CVD and obesity in transitional Syria: a perspective from the Middle East

Barakat H, Barakat H, Baaj MK

Vascular Health and Risk Management 2012, 8:145-150

Published Date: 6 March 2012

Review

Differential pharmacology and benefit/risk of azilsartan compared to other sartans

Kurtz TW, Kajiya T

Vascular Health and Risk Management 2012, 8:133-143

Published Date: 28 February 2012

Review

Absorbable stent: focus on clinical applications and benefits

Gonzalo N, Macaya C

Vascular Health and Risk Management 2012, 8:125-132

Published Date: 29 February 2012

Review

Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty

Shah A, Feldman DN

Vascular Health and Risk Management 2012, 8:115-123

Published Date: 27 February 2012

Review

Challenges for heart disease stem cell therapy

Hoover-Plow J, Gong Y

Vascular Health and Risk Management 2012, 8:99-113

Published Date: 17 February 2012

Review

Sudden death in eating disorders

Jáuregui-Garrido B, Jáuregui-Lobera I

Vascular Health and Risk Management 2012, 8:91-98

Published Date: 15 February 2012

Review

Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options

Fintel DJ

Vascular Health and Risk Management 2012, 8:77-89

Published Date: 15 February 2012

Review

Evolving role of platelet function testing in coronary artery interventions

Sharma RK, Voelker DJ, Sharma R, Reddy HK, Dod H, Marsh JD

Vascular Health and Risk Management 2012, 8:65-75

Published Date: 8 February 2012

Original Research

Doppler ultrasound venous mapping of the lower limbs

Galeandro AI, Quistelli G, Scicchitano P, Gesualdo M, Zito A, Caputo P, Carbonara R, Galgano G, Ciciarello F, Mandolesi S, Franceschi C, Ciccone MM

Vascular Health and Risk Management 2012, 8:59-64

Published Date: 7 February 2012

Review

New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders

Dahl OE

Vascular Health and Risk Management 2012, 8:45-57

Published Date: 25 January 2012

Original Research

Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy

Toth PP, Thakker KM, Jiang P, Padley RJ

Vascular Health and Risk Management 2012, 8:39-44

Published Date: 25 January 2012

Original Research

Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and women

Maki KC, Dicklin MR, Davidson MH, Mize PD, Kulkarni KR

Vascular Health and Risk Management 2012, 8:31-38

Published Date: 16 January 2012

Original Research

Predictors of poor blood pressure control assessed by 24 hour monitoring in patients with type B acute aortic dissection

Delsart P, Midulla M, Sobocinski J, Achere C, Haulon S, Claisse G, Mounier-Vehier C

Vascular Health and Risk Management 2012, 8:23-30

Published Date: 10 January 2012

Original Research

Metabolic syndrome and its components associated with endothelial dysfunction in chronic kidney disease patients

Bai Q, Lai X, Zhang AH, Lu XH, Tian SL, Fan MH, Wang Y, Wang T

Vascular Health and Risk Management 2012, 8:15-21

Published Date: 6 January 2012

Original Research

The impact of diurnal fasting during Ramadan on the lipid profile, hs-CRP, and serum leptin in stable cardiac patients

Khafaji HARH, Bener A, Osman M, Al Merri A, Al Suwaidi J

Vascular Health and Risk Management 2012, 8:7-14

Published Date: 30 December 2011

Original Research

Blood pressure and blood viscosity are not correlated in normal healthy subjects

Salazar Vázquez BY

Vascular Health and Risk Management 2012, 8:1-6

Published Date: 30 December 2011

Review

Benefits of once-daily therapies in the treatment of hypertension

Flack JM, Nasser SA

Vascular Health and Risk Management 2011, 7:777-787

Published Date: 21 December 2011

Original Research

The effect of chronic heart failure and type 2 diabetes on insulin-stimulated endothelial function is similar and additive

Falskov B, Hermann TS, Rask-Madsen C, Major-Pedersen A, Christiansen B, Raunsø J, Køber L, Torp-Pedersen C, Dominguez H

Vascular Health and Risk Management 2011, 7:771-776

Published Date: 19 December 2011

Original Research

Office and ambulatory blood pressure control with a fixed-dose combination of candesartan and hydrochlorothiazide in previously uncontrolled hypertensive patients: results of CHILI CU Soon

Mengden T, Hübner R, Bramlage P

Vascular Health and Risk Management 2011, 7:761-769

Published Date: 12 December 2011

Review

Differential clinical profile of candesartan compared to other angiotensin receptor blockers

Cernes R, Mashavi M, Zimlichman R

Vascular Health and Risk Management 2011, 7:749-759

Published Date: 12 December 2011

Review

Critical review of cancer risk associated with angiotensin receptor blocker therapy

Wuerzner G, Burnier M, Waeber B

Vascular Health and Risk Management 2011, 7:741-747

Published Date: 12 December 2011

Review

Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension

Palatini P, Casiglia E, Gąsowski J, Głuszek J, Jankowski P, Narkiewicz K, Saladini F, Stolarz-Skrzypek K, Tikhonoff V, Van Bortel L, Wojciechowska W, Kawecka-Jaszcz K

Vascular Health and Risk Management 2011, 7:725-739

Published Date: 7 December 2011

Original Research

Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium

Roy SK, Cespedes A, Li D, Choi TY, Budoff MJ

Vascular Health and Risk Management 2011, 7:719-724

Published Date: 2 December 2011

Review

Validation of four automatic devices for self-measurement of blood pressure according to the international protocol of the European Society of Hypertension

Topouchian J, Agnoletti D, Blacher J, Youssef A, Ibanez I, Khabouth J, Khawaja S, Beaino L, Asmar R

Vascular Health and Risk Management 2011, 7:709-717

Published Date: 30 November 2011

Original Research

Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ

Duprez D, Ferdinand K, Purkayastha D, Samuel R, Wright R

Vascular Health and Risk Management 2011, 7:701-708

Published Date: 24 November 2011

Original Research

Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting

Vogt A, Schoelmerich A, Pollner F, Schlitt M, Raaz U, Maegdefessel L, Reindl I, Buerke M, Werdan K, Schlitt A

Vascular Health and Risk Management 2011, 7:693-699

Published Date: 22 November 2011

Original Research

Effect of alcohol and tobacco use on vascular dementia: a matched case control study

Takahashi PY, Caldwell CR, Targonski PV

Vascular Health and Risk Management 2011, 7:685-691

Published Date: 15 November 2011

Review

Telmisartan and cardioprotection

Akhrass PR, McFarlane SI

Vascular Health and Risk Management 2011, 7:677-683

Published Date: 15 November 2011

Review

Vitamin D status and peripheral arterial disease: evidence so far

Chua GT, Chan YC, Cheng SW

Vascular Health and Risk Management 2011, 7:671-675

Published Date: 15 November 2011

Case report

Hemorrhagic infarction at 33 days after birth in a healthy full-term neonate

Kubo Y, Ogasawara K, Kurose A, Kashimura H, Koji T, Otawara Y, Kamei J, Akasaka M, Sasaki M, Ogawa A

Vascular Health and Risk Management 2011, 7:667-670

Published Date: 8 November 2011

Original Research

Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease

Mohammadi A, Sedani HH, Ghasemi-Rad M

Vascular Health and Risk Management 2011, 7:661-665

Published Date: 7 November 2011

Case report

Aneurysm of the tibial-saphenous fistula in hemodialysis patient: the results of surgical treatment

Günday M

Vascular Health and Risk Management 2011, 7:657-660

Published Date: 1 November 2011

Original Research

Central aortic blood pressure, augmentation index, and reflected wave transit time: reproducibility and repeatability of data obtained by oscillometry

Ageenkova OA, Purygina MA

Vascular Health and Risk Management 2011, 7:649-656

Published Date: 1 November 2011

Original Research

Current state of cardiac rehabilitation in Germany: patient characteristics, risk factor management and control status, by education level

Bestehorn K, Jannowitz C, Horack M, Karmann B, Halle M, Völler H

Vascular Health and Risk Management 2011, 7:639-647

Published Date: 31 October 2011

Original Research

Effects of smoking cessation on central blood pressure and arterial stiffness

Takami T, Saito Y

Vascular Health and Risk Management 2011, 7:633-638

Published Date: 20 October 2011

Original Research

Prevalence of significant carotid artery stenosis in Iranian patients with peripheral arterial disease

Bavil AS, Ghabili K, Daneshmand SE, Nemati M, Bavil MS, Namdar H, Shaafi S

Vascular Health and Risk Management 2011, 7:629-632

Published Date: 11 October 2011

Case report

Retrograde rotational thrombectomy with the Rotarex® catheter system: treatment option for an acute thrombotic occlusion of a subclavian artery

Lichtenberg M, Kaeunicke M, Lukat M, Hailer B

Vascular Health and Risk Management 2011, 7:623-627

Published Date: 30 September 2011

Review

Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk

Farsang C

Vascular Health and Risk Management 2011, 7:605-622

Published Date: 26 September 2011

Review

Troponin elevation in conditions other than acute coronary syndromes

Tanindi A, Cemri M

Vascular Health and Risk Management 2011, 7:597-603

Published Date: 22 September 2011

Original Research

Signs for early diagnosis of heart failure in primary health care

Devroey D, Van Casteren V

Vascular Health and Risk Management 2011, 7:591-596

Published Date: 14 September 2011

Original Research

Value of venous color flow duplex scan as initial screening test for geriatric inpatients with clinically suspected pulmonary embolism

Kreidy R, Stephan E, Salameh P, Waked M

Vascular Health and Risk Management 2011, 7:585-589

Published Date: 15 September 2011

Perspectives

Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials

Grossman E, Laudon M, Zisapel N

Vascular Health and Risk Management 2011, 7:577-584

Published Date: 15 September 2011

Review

Superficial venous thrombosis: disease progression and evolving treatment approaches

Litzendorf ME, Satiani B

Vascular Health and Risk Management 2011, 7:569-575

Published Date: 31 August 2011

Review

Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention

Pham PA, Pham PT, Pham PC, Miller JM, Pham PM, Pham SV

Vascular Health and Risk Management 2011, 7:551-567

Published Date: 26 August 2011

Original Research

Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production

Brown MD, Feairheller DL, Thakkar S, Veerabhadrappa P, Park JY

Vascular Health and Risk Management 2011, 7:541-550

Published Date: 26 August 2011

Review

Extended-release ranolazine: critical evaluation of its use in stable angina

Truffa AAM, Newby LK, Melloni C

Vascular Health and Risk Management 2011, 7:535-539

Published Date: 25 August 2011

Review

Lipid-lowering therapy: who can benefit

Lewis SJ

Vascular Health and Risk Management 2011, 7:525-534

Published Date: 24 August 2011

Original Research

Arterial function of carotid and brachial arteries in postmenopausal vegetarians

Su TC, Torng PL, Jeng JS, Chen MF, Liau CS

Vascular Health and Risk Management 2011, 7:517-523

Published Date: 23 August 2011

Original Research

Combined determination of highly sensitive troponin T and copeptin for early exclusion of acute myocardial infarction: first experience in an emergency department of a general hospital

Lotze U, Lemm H, Heyer A, Müller K

Vascular Health and Risk Management 2011, 7:509-515

Published Date: 19 August 2011

Original Research

Renal artery stenosis in kidney transplants: assessment of the risk factors

Etemadi J, Rahbar K, Haghighi AN, Bagheri N, Falaknazi K, Ardalan MR, Ghabili K, Shoja MM

Vascular Health and Risk Management 2011, 7:503-507

Published Date: 10 August 2011

Original Research

Comparing patients with spinal cord infarction and cerebral infarction: clinical characteristics, and short-term outcome

Naess H, Romi F

Vascular Health and Risk Management 2011, 7:497-502

Published Date: 4 August 2011

Original Research

Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study

Radaideh G, Choueiry P, Ismail A, Eid E, Berrou JP, Sedefdjian A, Sévenier F, Pathak A

Vascular Health and Risk Management 2011, 7:491-495

Published Date: 1 August 2011

Original Research

Incident prediabetes/diabetes and blood pressure in urban and rural communities in the Democratic Republic of Congo

Hightower JD, Hightower CM, Salazar Vázquez BY, Intaglietta M

Vascular Health and Risk Management 2011, 7:483-489

Published Date: 22 July 2011

Original Research

Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects

Sugiura T, Dohi Y, Takase H, Yamashita S, Tanaka S, Kimura G

Vascular Health and Risk Management 2011, 7:475-482

Published Date: 19 July 2011

Review

Pre-eclampsia: pathophysiology, diagnosis, and management

Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J-M

Vascular Health and Risk Management 2011, 7:467-474

Published Date: 19 July 2011

Review

Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data

Kwong LM

Vascular Health and Risk Management 2011, 7:461-466

Published Date: 18 July 2011

Review

Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview

Hillegass WB, Brott BC, Dobbs JC, Papapietro SE, Misra VK, Zoghbi GJ

Vascular Health and Risk Management 2011, 7:445-459

Published Date: 18 July 2011

Review

Depression in vascular pathologies: the neurologist's point of view

Moretti R, Bernobich E, Esposito F, Torre P, Antonello RM, De Angelis L, Bellini G

Vascular Health and Risk Management 2011, 7:433-443

Published Date: 12 July 2011

Original Research

Racial differences in the responses to shear stress in human umbilical vein endothelial cells

Feairheller DL, Park J-Y, Rizzo V, Kim B, Brown MD

Vascular Health and Risk Management 2011, 7:425-431

Published Date: 11 July 2011

Original Research

Risk factor investigation for cardiovascular health through WHO STEPS approach in Ardabil, Iran

Sadeghi-Bazargani H, Jafarzadeh H, Fallah M, Hekmat S, Bashiri J, Hosseingolizadeh GH, Soltanmohammadzadeh MS, Mortezazadeh A, Shaker A, Danehzan M, Zohouri A, Khosravi O, Nasimidoust R, Malekpour N, Kharazmi E, Babaei M, Nadirmohammadi M, Mashhadi-Abdoll H

Vascular Health and Risk Management 2011, 7:417-424

Published Date: 11 July 2011

Review

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil

Mason RP

Vascular Health and Risk Management 2011, 7:405-416

Published Date: 24 June 2011

Original Research

Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention

Kwan J, Htun WW, Huang Y, Ko W, Kwan T

Vascular Health and Risk Management 2011, 7:399-404

Published Date: 24 June 2011

Review

Cardiovascular outcomes with angiotensin II receptor blockers: clinical implications of recent trials

Baumhäkel M, Böhm M

Vascular Health and Risk Management 2011, 7:391-397

Published Date: 23 June 2011

Original Research

Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study

Takami T, Saito Y

Vascular Health and Risk Management 2011, 7:383-390

Published Date: 17 June 2011

Original Research

Stiffness of the large arteries in individuals with and without Down syndrome

Rodrigues AN, Coelho LC, Goncalves WLS, Gouvea SA, Vasconcellos MJR, Cunha RS, Abreu GR

Vascular Health and Risk Management 2011, 7:375-381

Published Date: 9 June 2011

Original Research

Chasing the reflected wave back into the heart: a new hypothesis while the jury is still out

Codreanu I, Robson MD, Rider OJ, Pegg TJ, Jung BA, Dasanu CA, Clarke K, Holloway CJ

Vascular Health and Risk Management 2011, 7:365-373

Published Date: 8 June 2011

Review

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure

Nappi J, Sieg A

Vascular Health and Risk Management 2011, 7:353-363

Published Date: 8 June 2011

Review

Stentless aortic valve replacement: an update

Kobayashi J

Vascular Health and Risk Management 2011, 7:345-351

Published Date: 2 June 2011

Original Research

Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation

Sezer ED, Sozmen EY, Nart D, Onat T

Vascular Health and Risk Management 2011, 7:333-343

Published Date: 1 June 2011

Original Research

The occurrence of left ventricular hypertrophy in normotensive individuals in a community setting in North-East Trinidad

Bacchus R, Singh K, Ogeer I, Mungrue K

Vascular Health and Risk Management 2011, 7:327-332

Published Date: 6 July 2011

Original Research

Early follow-up results of arteriovenous fistulae created for hemodialysis

Iyem H

Vascular Health and Risk Management 2011, 7:321-325

Published Date: 19 May 2011

Review

Reappraisal of role of angiotensin receptor blockers in cardiovascular protection

Ram C

Vascular Health and Risk Management 2011, 7:315-319

Published Date: 15 May 2011

Review

A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors

Siragy HM

Vascular Health and Risk Management 2011, 7:297-313

Published Date: 19 May 2011

Review

Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods

Barbosa J, Rodrigues A, Mota C, Barbosa M, Simoes e Silva AC

Vascular Health and Risk Management 2011, 7:287-295

Published Date: 10 May 2011

Original Research

Cognitive evolution in hypertensive patients: a six-year follow-up

Vicario A, del Sueldo MA, Zilberman JM, Cerezo GH

Vascular Health and Risk Management 2011, 7:281-285

Published Date: 5 May 2011

Original Research

Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta

Xue Y-L, Shi H-X, Murad F, Bian K

Vascular Health and Risk Management 2011, 7:273-280

Published Date: 28 April 2011

Review

Relating patenting and peer-review publications: an extended perspective on the vascular health and risk management literature

Mucke HAM

Vascular Health and Risk Management 2011, 7:265-272

Published Date: 18 April 2011

Review

Surgery in current therapy for infective endocarditis

Head SJ, Mokhles MM, Osnabrugge RLJ, Bogers AJJC, Kappetein AP

Vascular Health and Risk Management 2011, 7:255-263

Published Date: 19 April 2011

Review

The causes, consequences, and treatment of left or right heart failure

Pazos-Lopez P, Peteiro-Vazquez J, Garcia-Campos A, Garcia-Bueno L, Abugattas-de-Torres JP, Castro-Beiras A

Vascular Health and Risk Management 2011, 7:237-254

Published Date: 4 April 2011

Review

Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program

Abraham I, MacDonald K, Hermans C, Aerts A, Lee C, Brié H, Vancayzeele S

Vascular Health and Risk Management 2011, 7:209-235

Published Date: 31 March 2011

Original Research

Doppler study of cerebral arteries in hypercholesterolemia

Farhoudi M, Mehrvar K, Aslanabadi N, Ghabili K, Baghmishe NR, Ilkhchoei F

Vascular Health and Risk Management 2011, 7:203-207

Published Date: 31 March 2011

Review

The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation

Schmidt C, Kisselbach J, Schweizer PA, Katus HA, Thomas D

Vascular Health and Risk Management 2011, 7:193-202

Published Date: 31 March 2011

Review

Olmesartan/amlodipine: a review of its use in the management of hypertension

Kreutz R

Vascular Health and Risk Management 2011, 7:183-192

Published Date: 29 March 2011

Review

Olmesartan medoxomil for the treatment of hypertension in children and adolescents

Tocci G, Volpe M

Vascular Health and Risk Management 2011, 7:177-181

Published Date: 31 March 2011

Review

Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders

Mingorance C, Rodríguez-Rodríguez R, Justo ML, Alvarez de Sotomayor M, Herrera MD

Vascular Health and Risk Management 2011, 7:169-176

Published Date: 28 March 2011

Case report

Angiographic estimation of atherosclerotic disease burden in a coronary artery fed by collaterals: a potential pitfall in decision for revascularization

Grigorios Tsigkas, Panagiota Mylona, Periklis Davlouros, et al

Vascular Health and Risk Management 2011, 7:165-167

Published Date: 22 March 2011

Review

Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications

Carlos V Serrano Jr, Karina Tiemi Setani, Erica Sakamoto, et al

Vascular Health and Risk Management 2011, 7:159-164

Published Date: 16 March 2011

Original Research

Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome – a comprehensive cancer center experience

Hikmat N Abdel-Razeq, Asem H Mansour, Yousef M Ismael

Vascular Health and Risk Management 2011, 7:153-158

Published Date: 15 March 2011

Review

Skeletonized coronary arteries: pathophysiological and clinical aspects of vascular calcification

Carlos V Serrano Jr, Marcelo Oranges, Vitor Brunaldi, et al

Vascular Health and Risk Management 2011, 7:143-151

Published Date: 9 March 2011

Review

Treatment options for hypertension in high-risk patients

Wei-Chuan Tsai

Vascular Health and Risk Management 2011, 7:137-141

Published Date: 9 March 2011

Letter

Coronary sinus intervention for the treatment of refractory angina pectoris

Yoav Paz, Amihay Shinfeld

Vascular Health and Risk Management 2011, 7:135-136

Published Date: 3 March 2011

Original Research

Cardiovascular risk evaluation and prevalence of silent myocardial ischemia in subjects with asymptomatic carotid artery disease

Marco Matteo Ciccone, Asabella Artor Niccoli, Pietro Scicchitano, et al

Vascular Health and Risk Management 2011, 7:129-134

Published Date: 4 March 2011

Case report

The value of blood D-dimer test in the diagnosis of walk-in patients with venous thromboembolism

Shozo Yasuoka, Shunichiro Kubota

Vascular Health and Risk Management 2011, 7:125-127

Published Date: 1 March 2011

Original Research

Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension

Zeenat Safdar

Vascular Health and Risk Management 2011, 7:119-124

Published Date: 2 March 2011

Review

Novel drug-eluting stents in the treatment of de novo coronary lesions

Davide Capodanno, Fabio Dipasqua, Corrado Tamburino

Vascular Health and Risk Management 2011, 7:103-118

Published Date: 25 February 2011

Original Research

Endothelial function in a cardiovascular risk population with borderline ankle–brachial index

Kari Syvänen, Päivi Korhonen, Auli Partanen, et al

Vascular Health and Risk Management 2011, 7:97-101

Published Date: 23 February 2011

Original Research

Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T)

Gerd Bönner, Bernhard Landers, Peter Bramlage

Vascular Health and Risk Management 2011, 7:85-95

Published Date: 17 February 2011

Original Research

Decline of arterial cerebral infarction among young women: the Bergen Stroke Study

Halvor Naess, Annette Fromm, Ole Erik Iversen, et al

Vascular Health and Risk Management 2011, 7:81-84

Published Date: 15 February 2011

Original Research

Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus

Samuel O Olusi, Sunila George

Vascular Health and Risk Management 2011, 7:75-80

Published Date: 15 February 2011

Original Research

Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study

Ersen B Colkesen, Bart S Ferket, Jan GP Tijssen, et al

Vascular Health and Risk Management 2011, 7:67-74

Published Date: 9 February 2011

Original Research

Exercise electrocardiographic responses and serum cystatin C levels among metabolic syndrome patients without overt diabetes mellitus

Asli Tanindi, Hilal Olgun, Ayse Tuncel, et al

Vascular Health and Risk Management 2011, 7:59-65

Published Date: 6 February 2011

Original Research

Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies

Anja Schweizer, Sylvie Dejager, James E Foley, et al

Vascular Health and Risk Management 2011, 7:49-57

Published Date: 4 February 2011

Original Research

Relevance of tumor angiogenesis patterns as a diagnostic value and prognostic indicator in oral precancer and cancer

Devi Charan Shetty, Puneet Ahuja, DK Taneja, et al

Vascular Health and Risk Management 2011, 7:41-47

Published Date: 27 January 2011

Case report

Congenital agenesis of internal carotid artery with ipsilateral Horner presenting as focal neurological symptoms

Wassim Farhat, Rechdi Ahdab, Hassan Hosseini

Vascular Health and Risk Management 2011, 7:37-40

Published Date: 26 January 2011

Original Research

Hyperhomocysteinemia decreases bone blood flow

Neetu Tyagi, Thomas P Vacek, John T Fleming, et al

Vascular Health and Risk Management 2011, 7:31-35

Published Date: 25 January 2011

Review

Antiplatelet combinations for prevention of atherothrombotic events

Mario Bollati, Fiorenzo Gaita, Matteo Anselmino

Vascular Health and Risk Management 2011, 7:23-30

Published Date: 12 January 2011

Original Research

ACE up the sleeve – are vascular patients medically optimized

AP Coveney, GC O'Brien, GJ Fulton

Vascular Health and Risk Management 2011, 7:15-21

Published Date: 7 January 2011

Review

Considering statins for cholesterol-reduction in children if lifestyle and diet changes do not improve their health: a review of the risks and benefits

Clodagh SM O’Gorman, Michael B O’Neill, Louise S Conwell

Vascular Health and Risk Management 2011, 7:1-14

Published Date: 20 December 2010

Original Research

COSEHC global vascular risk management quality improvement program: rationale and design

Carlos M Ferrario, Michael A Moore, William Bestermann Jr, et al

Vascular Health and Risk Management 2010, 6:1135-1145

Published Date: 13 December 2010

Original Research

Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing

Emily Dey-Hazra, Barbara Hertel, Torsten Kirsch, et al

Vascular Health and Risk Management 2010, 6:1125-1133

Published Date: 6 December 2010

Review

Inhaled treprostinil and pulmonary arterial hypertension

Samuel T Nadler, Jeffrey D Edelman

Vascular Health and Risk Management 2010, 6:1115-1124

Published Date: 3 December 2010

Case report

Stent-grafts in the management of life-threatening hemorrhage following inadvertent femoral catheterization in high-risk patients: report of two cases and review of the literature

Abdullah Al Wahbi

Vascular Health and Risk Management 2010, 6:1111-1114

Published Date: 3 December 2010

Original Research

Lower extremity arterial injuries over a six-year period: outcomes, risk factors, and management

Aşkin Ender Topal, Mehmet Nesimi Eren, Yusuf Celik

Vascular Health and Risk Management 2010, 6:1103-1110

Published Date: 3 December 2010

Review

Insulin therapy in critically ill patients

Samer Ellahham

Vascular Health and Risk Management 2010, 6:1089-1101

Published Date: 1 December 2010

Review

Optimal management of familial hypercholesterolemia: treatment and management strategies

Mohammad Hassan Nemati, Behrooz Astaneh

Vascular Health and Risk Management 2010, 6:1079-1088

Published Date: 3 December 2010

Case report

Percutaneous coronary intervention of a single coronary artery arising from the right sinus of Valsalva

Mehmet Akif Cakar, Ersan Tatli, Bilhan Ozalp, et al

Vascular Health and Risk Management 2010, 6:1077-1078

Published Date: 25 November 2010

Original Research

Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy

William Insull Jr, Peter P Toth, H Robert Superko, et al

Vascular Health and Risk Management 2010, 6:1065-1075

Published Date: 24 November 2010

Review

Cardio classics revisited – focus on the role of candesartan

Maria Leonarda De Rosa

Vascular Health and Risk Management 2010, 6:1047-1063

Published Date: 23 November 2010

Original Research

Computerized history-taking as a tool to manage dyslipidemia

David Zakim, Christine Fritz, Niko Braun, et al

Vascular Health and Risk Management 2010, 6:1039-1046

Published Date: 12 November 2010

Review

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia

Ian Hamilton-Craig, Karam Kostner, David Colquhoun, et al

Vascular Health and Risk Management 2010, 6:1023-1037

Published Date: 10 November 2010

Original Research

Prognostic value of changes in arterial stiffness in men with coronary artery disease

Iana A Orlova, Eradzh Yu Nuraliev, Elena B Yarovaya, et al

Vascular Health and Risk Management 2010, 6:1015-1021

Published Date: 4 November 2010

Original Research

Effects of safflower seed extract on arterial stiffness

Katsuya Suzuki, Shigekazu Tsubaki, Masami Fujita, et al

Vascular Health and Risk Management 2010, 6:1007-1014

Published Date: 3 November 2010

Review

Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia

Jun Sasaki

Vascular Health and Risk Management 2010, 6:997-1005

Published Date: 2 November 2010

Review

Low high-density lipoprotein cholesterol: current status and future strategies for management

Vibhuti Singh, Rakesh Sharma, Ajoy Kumar, et al

Vascular Health and Risk Management 2010, 6:979-996

Published Date: 29 October 2010

Review

Ticagrelor: An investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome

Eitan Abergel, Eugenia Nikolsky

Vascular Health and Risk Management 2010, 6:963-977

Published Date: 19 October 2010

Original Research

Hypothyroidism and the risk of lower extremity arterial disease

Michael A Mazzeffi, Hung-Mo Lin, Brigid C Flynn, et al

Vascular Health and Risk Management 2010, 6:957-962

Published Date: 20 October 2010

Review

Risk assessment and aspirin use in Asian and Western populations

Runlin Gao, Xiaoying Li

Vascular Health and Risk Management 2010, 6:943-956

Published Date: 14 October 2010

Original Research

Diagnostic accuracy of dual-source CT angiography and coronary risk stratification

Xia Yang, Lu-yue Gai, Ping Li, et al

Vascular Health and Risk Management 2010, 6:935-941

Published Date: 14 October 2010

Original Research

Impact of a diabetic foot care education program on lower limb amputation rate

Abdullah M Al-Wahbi

Vascular Health and Risk Management 2010, 6:923-934

Published Date: 11 October 2010

Review

Small coronary vessel angioplasty: outcomes and technical considerations

Sudhir Rathore

Vascular Health and Risk Management 2010, 6:915-922

Published Date: 11 October 2010

Original Research

Costs and outcomes of noncardioembolic ischemic stroke in a managed care population

Nicole M Engel-Nitz, Stephen D Sander, Carolyn Harley, et al

Vascular Health and Risk Management 2010, 6:905-913

Published Date: 5 October 2010

Review

Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies

Christina Voulgari, Dimitrios Papadogiannis, Nicholas Tentolouris

Vascular Health and Risk Management 2010, 6:883-903

Published Date: 11 October 2010

Review

New class of agents for treatment of hypertension: Focus on direct renin inhibition

Roberto Fogari, Annalisa Zoppi

Vascular Health and Risk Management 2010, 6:869-882

Published Date: 1 October 2010

Review

Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update

Juan V Llau, Raquel Ferrandis, Pilar Sierra, et al

Vascular Health and Risk Management 2010, 6:855-867

Published Date: 29 September 2010

Review

Benefits of statin therapy and compliance in high risk cardiovascular patients

Joel A Lardizabal, Prakash C Deedwania

Vascular Health and Risk Management 2010, 6:843-853

Published Date: 23 September 2010

Original Research

Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study

Laura J Gray, Jennifer R Tringham, Melanie J Davies, et al

Vascular Health and Risk Management 2010, 6:837-842

Published Date: 20 September 2010

Review

Lifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesis

Jørn Ditzel, Hans-Henrik Lervang

Vascular Health and Risk Management 2010, 6:829-836

Published Date: 17 September 2010

Original Research

Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients

Maurizio Destro, Nora Crikelair, Joseph Yen, et al.

Vascular Health and Risk Management 2010, 6:821-827

Published Date: 6 September 2010

Review

Argatroban in the management of heparin-induced thrombocytopenia

Luciano Babuin, Vittorio Pengo

Vascular Health and Risk Management 2010, 6:813-819

Published Date: 1 September 2010

Original Research

Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice

Peter Bramlage, Wolf-Peter Wolf, Thomas Stuhr, et al

Vascular Health and Risk Management 2010, 6:803-811

Published Date: 27 August 2010

Review

Management of acute attacks of hereditary angioedema: potential role of icatibant

Hilary J Longhurst

Vascular Health and Risk Management 2010, 6:795-802

Published Date: 6 September 2010

Review

Role of endothelin receptor A and NADPH oxidase in vascular abnormalities

De-Zai Dai, Yin Dai

Vascular Health and Risk Management 2010, 6:787-794

Published Date: 3 September 2010

Review

Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review

Suzanne A Ligthart, Eric P Moll van Charante, Willem A Van Gool, et al

Vascular Health and Risk Management 2010, 6:775-785

Published Date: 17 August 2010

Review

Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization

Richard Kones

Vascular Health and Risk Management 2010, 6:749-774

Published Date: 12 August 2010

Review

Effectiveness of percutaneous laser revascularization therapy for refractory angina

Michael McGillion, Allison Cook, J Charles Victor, et al

Vascular Health and Risk Management 2010, 6:735-747

Published Date: 26 August 2010

Rapid Communication

Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells

Myriam Iglewski, Stephen R Grant

Vascular Health and Risk Management 2010, 6:723-734

Published Date: 11 August 2010

Review

Aliskiren and valsartan combination therapy for the management of hypertension

Benjamin J Epstein

Vascular Health and Risk Management 2010, 6:711-722

Published Date: 11 August 2010

Review

Role of olmesartan in combination therapy in blood pressure control and vascular function

Carlos M Ferrario, Ronald D Smith

Vascular Health and Risk Management 2010, 6:701-709

Published Date: 9 August 2010

Review

The utility of troponin measurement to detect myocardial infarction: review of the current findings

Melissa A Daubert, Allen Jeremias

Vascular Health and Risk Management 2010, 6:691-699

Published Date: 5 August 2010

Review

Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment

Curtis Triplitt, Eugenio Cersosimo, Ralph A DeFronzo

Vascular Health and Risk Management 2010, 6:671-690

Published Date: 5 August 2010

Review

Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?

Ajoy Kumar, Vibhuti Singh

Vascular Health and Risk Management 2010, 6:665-669

Published Date: 30 July 2010

Original Research

Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction

Elmir Omerovic, Truls Råmunddal, Per Albertsson, et al

Vascular Health and Risk Management 2010, 6:657-663

Published Date: 26 August 2010

Review

Recent advances in the management of chronic stable angina I: Approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities

Richard Kones

Vascular Health and Risk Management 2010, 6:635-656

Published Date: 15 July 2010

Other

MRI sagittal abdominal diameter is a stronger predictor of metabolic syndrome than visceral fat area or waist circumference in a high-risk vascular cohort

Michel R Hoenig

Vascular Health and Risk Management 2010, 6:629-633

Published Date: 16 July 2010

Original Research

Estimating glomerular filtration rate in a population-based study

Anoop Shankar, Kristine E Lee, Barbara EK Klein, et al

Vascular Health and Risk Management 2010, 6:619-627

Published Date: 16 July 2010

Case Series

Management of high-risk popliteal vascular blunt trauma: clinical experience with 62 cases

Ali Pourzand, Bassir A Fakhri, Ramin Azhough, et al

Vascular Health and Risk Management 2010, 6:613-618

Published Date: 14 July 2010

Review

Cardiac risk stratification: Role of the coronary calcium score

Rakesh K Sharma, Rajiv K Sharma, Donald J Voelker, et al

Vascular Health and Risk Management 2010, 6:603-611

Published Date: 14 July 2010

Review

Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy

Claudio A Muratore, Adrian Baranchuk

Vascular Health and Risk Management 2010, 6:593-601

Published Date: 14 July 2010

Review

Using noncontrast cardiac CT and coronary artery calcification measurements for cardiovascular risk assessment and management in asymptomatic adults

John A Rumberger

Vascular Health and Risk Management 2010, 6:579-591

Published Date: 7 July 2010

Original Research

Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome

Kanako Bokuda, Atsuhiro Ichihara, Mariyo Sakoda, et al

Vascular Health and Risk Management 2010, 6:571-578

Published Date: 5 July 2010

Review

Practical recommendations for treatment of hypertension in older patients

Philip A Kithas, Mark A Supiano

Vascular Health and Risk Management 2010, 6:561-569

Published Date: 29 June 2010

Review

Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination

Francesca Cagnoni, Christian Achiri Ngu Njwe, Augusto Zaninelli, et al

Vascular Health and Risk Management 2010, 6:549-559

Published Date: 28 June 2010

Review

Weight neutrality with the DPP-4 inhibitor, vildagliptin: Mechanistic basis and clinical experience

James E Foley, Jens Jordan

Vascular Health and Risk Management 2010, 6:541-548

Published Date: 1 July 2010

Review

Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid

Elisavet Moutzouri, Anastazia Kei, Moses S Elisaf, et al

Vascular Health and Risk Management 2010, 6:525-539

Published Date: 29 June 2010

Review

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy

Deborah Wolbrette, Mario Gonzalez, Soraya Samii, et al

Vascular Health and Risk Management 2010, 6:517-523

Published Date: 28 June 2010

Original Research

Clinical profile of hypertension at a University Teaching Hospital in Nigeria

Arthur C Onwuchekwa, Sunday Chinenye

Vascular Health and Risk Management 2010, 6:511-516

Published Date: 1 July 2010

Review

Transradial approach to lower extremity interventions

Ravikiran Korabathina, Sidharth S Yadav, John T Coppola, et al

Vascular Health and Risk Management 2010, 6:503-509

Published Date: 1 July 2010

Original Research

Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG

Sandra Eifert, Helmut Mair, Anne-Laure Boulesteix, et al

Vascular Health and Risk Management 2010, 6:495-501

Published Date: 29 June 2010

Review

Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection

Domenico Galzerano, Cristina Capogrosso, Sara Di Michele, et al

Vascular Health and Risk Management 2010, 6:479-494

Published Date: 22 June 2010

Original Research

Congestive heart failure in subjects with thyrotoxicosis in a black community

R C Anakwue, B J C Onwubere, B C Anisiuba, et al

Vascular Health and Risk Management 2010, 6:473-477

Published Date: 5 July 2010

Review

Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia

Hugo Van Herendael, Paul Dorian

Vascular Health and Risk Management 2010, 6:465-472

Published Date: 21 June 2010

Review

Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review

Ahmed S Awad, Michael E Goldberg

Vascular Health and Risk Management 2010, 6:457-464

Published Date: 9 June 2010

Original Research

Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure

Inder S Anand, Anita Deswal, Dean J Kereiakes, et al

Vascular Health and Risk Management 2010, 6:449-455

Published Date: 1 June 2010

Review

Novel approaches for the surgical treatment of atrial fibrillation: Time for a guideline revision?

Carlo Nicola De Cecco, Vitaliano Buffa, Vincenzo David, et al

Vascular Health and Risk Management 2010, 6:439-447

Published Date: 9 June 2010

Original Research

Influence of demographic and metabolic variables on forearm blood flow and vascular conductance in individuals without overt heart disease

Thiago E Sartori, Rafael AB Nunes, Gisela T da Silva, et al

Vascular Health and Risk Management 2010, 6:431-437

Published Date: 31 May 2010

Review

Novel antiplatelet agents in the prevention of cardiovascular complications – focus on ticagrelor

Margaret M Marczewski, Marek Postula, Dariusz Kosior

Vascular Health and Risk Management 2010, 6:419-429

Published Date: 24 May 2010

Review

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure

A Palazzuoli, M Gallotta, I Quatrini, et al

Vascular Health and Risk Management 2010, 6:411-418

Published Date: 26 May 2010

Review

An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog

Katarina Raslova

Vascular Health and Risk Management 2010, 6:399-410

Published Date: 24 May 2010

Review

Heart rate control with adrenergic blockade: Clinical outcomes in cardiovascular medicine

David Feldman, Terry S Elton, Doron M Menachemi, et al

Vascular Health and Risk Management 2010, 6:387-397

Published Date: 24 May 2010

Case report

Isolated spontaneous dissection of the celiac trunk in a patient with bicuspid aortic valve

Abdel-Rauf Zeina, Alicia Nachtigal, Anton Troitsa, et al

Vascular Health and Risk Management 2010, 6:383-386

Published Date: 19 May 2010

Original Research

Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes

Magnus Dencker, Martin Stagmo, Mozhgan Dorkhan

Vascular Health and Risk Management 2010, 6:373-382

Published Date: 18 May 2010

Review

Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence

Janet B McGill

Vascular Health and Risk Management 2010, 6:363-372

Published Date: 26 May 2010

Review

Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia

Peter Alagona Jr

Vascular Health and Risk Management 2010, 6:351-362

Published Date: 13 May 2010

Review

New options with dabigatran etexilate in anticoagulant therapy

Lars Maegdefessel, Joshua M Spin, Junya Azuma, et al

Vascular Health and Risk Management 2010, 6:339-349

Published Date: 10 May 2010

Original Research

Should we screen for masked hypertension in patient with vascular disease?

Pascal Delsart, Philippe Marboeuf, Cedric Delhaye, et al

Vascular Health and Risk Management 2010, 6:333-338

Published Date: 10 May 2010

Original Research

Effect of lipopenic and hypotensive treatment on homocysteine levels in type 2 diabetics

Mabrouka El Oudi, Zied Aouni, Haroun Ouertani, et al

Vascular Health and Risk Management 2010, 6:327-332

Published Date: 13 May 2010

Review

Optimizing blood pressure control through the use of fixed combinations

Rainer Düsing

Vascular Health and Risk Management 2010, 6:321-325

Published Date: 10 May 2010

Case report

Volumetric capnography: In the diagnostic work-up of chronic thromboembolic disease

Marcos Mello Moreira, Renato Giuseppe Giovanni Terzi, Laura Cortellazzi, et al

Vascular Health and Risk Management 2010, 6:317-319

Published Date: 17 May 2010

Review

Coronary computed tomographic angiography (CCTA) in community hospitals: “current and emerging role”

Rakesh K Sharma, Donald J Voelker, Rajiv K Sharma, et al

Vascular Health and Risk Management 2010, 6:307-316

Published Date: 10 May 2010

Original Research

Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo)

Marco Matteo Ciccone, Ambrogio Aquilino, Francesca Cortese, et al

Vascular Health and Risk Management 2010, 6:297-305

Published Date: 28 April 2010

Original Research

Mortality following operations for lower extremity peripheral arterial disease

Tracie C Collins, David Nelson, Jasjit S Ahluwalia

Vascular Health and Risk Management 2010, 6:287-296

Published Date: 3 May 2010

Original Research

Predictors of obstructive sleep apnea in males with metabolic syndrome

Nikolaos Papanas, Paschalis Steiropoulos, Evangelia Nena, et al

Vascular Health and Risk Management 2010, 6:281-286

Published Date: 20 April 2010

Review

The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension

Jeremy A Falk, Kiran J Philip, Ernst R Schwarz

Vascular Health and Risk Management 2010, 6:273-280

Published Date: 20 April 2010

Original Research

Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial

Richard Grimm, Mobin Malik, Carla Yunis, et al

Vascular Health and Risk Management 2010, 6:261-271

Published Date: 16 April 2010

Review

Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update

Maurizio Destro, Francesca Cagnoni, Antonio D’Ospina, et al

Vascular Health and Risk Management 2010, 6:253-260

Published Date: 14 April 2010

Review

Managing anemia in patients with chronic heart failure: what do we know?

Ankur Sandhu, Sandeep Soman, Michael Hudson, et al

Vascular Health and Risk Management 2010, 6:237-252

Published Date: 7 April 2010

Review

Atorvastatin in stroke: a review of SPARCL and subgroup analysis

Branko N Huisa, Andrew B Stemer, Justin A Zivin

Vascular Health and Risk Management 2010, 6:229-236

Published Date: 30 March 2010

Original Research

Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function

Poulami Basu, Utpal Sen, Neetu Tyagi,  et al

Vascular Health and Risk Management 2010, 6:215-228

Published Date: 30 March 2010

Review

Recent achievements in the management of Raynaud’s phenomenon

Magnus Baumhäkel, Michael Böhm

Vascular Health and Risk Management 2010, 6:207-214

Published Date: 30 March 2010

Review

Does plasmin have anticoagulant activity?

Jane Hoover-Plow

Vascular Health and Risk Management 2010, 6:199-205

Published Date: 26 March 2010

Review

Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes

Toshikazu Yamanouchi

Vascular Health and Risk Management 2010, 6:189-197

Published Date: 23 March 2010

Review

Fondaparinux and acute coronary syndromes: update on the OASIS 5–6 studies

François Schiele

Vascular Health and Risk Management 2010, 6:179-187

Published Date: 26 March 2010

Review

Advances in the treatment of Raynaud’s phenomenon

Terri L Levien

Vascular Health and Risk Management 2010, 6:167-177

Published Date: 11 March 2010

Original Research

Prevalence and risk factors of microalbuminuria in Thai nondiabetic hypertensive patients

Pongsathorn Gojaseni, Angkana Phaopha, Worawon Chailimpamontree, et al

Vascular Health and Risk Management 2010, 6:157-165

Published Date: 11 March 2010

Review

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

Ajikumar V Aryangat, John E Gerich

Vascular Health and Risk Management 2010, 6:145-155

Published Date: 9 March 2010

Original Research

The diagnostic value of endothelial function as a potential sensor of fatigue in health

Yoshiko Ohno, Teruto Hashiguchi, Ryuichi Maenosono, et al

Vascular Health and Risk Management 2010, 6:135-144

Published Date: 9 March 2010

Review

New standards in hypertension and cardiovascular risk management: focus on telmisartan

Domenico Galzerano, Cristina Capogrosso, Sara Di Michele, et al

Vascular Health and Risk Management 2010, 6:113-133

Published Date: 4 March 2010

Commentary

Aspirin and clopidogrel resistance: methodological challenges and opportunities

Armen Yuri Gasparyan

Vascular Health and Risk Management 2010, 6:109-112

Published Date: 2 March 2010

Other

A newly designed hydroxyapatite ceramic burr-hole button

Hiroshi Kashimura, Kuniaki Ogasawara, Yoshitaka Kubo, et al

Vascular Health and Risk Management 2010, 6:105-108

Published Date: 3 March 2010

Review

Modern role for clopidogrel in management of atrial fibrillation and stroke reduction

Lars Maegdefessel, Junya Azuma, Philip S Tsao

Vascular Health and Risk Management 2010, 6:95-103

Published Date: 26 February 2010

Review

Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine

Roberto Fogari, Amedeo Mugellini, Paola Preti, et al

Vascular Health and Risk Management 2010, 6:87-93

Published Date: 22 February 2010

Review

Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy

Yun Lin, Shaymaa S Mousa, Nabil Elshourbagy, et al

Vascular Health and Risk Management 2010, 6:73-85

Published Date: 12 February 2010

Commentary

On the antiatherogenic effects of vitamin E: the search for the Holy Grail

Francesco Galli, Dimitrios Kirmizis, Dimitrios Chatzidimitriou

Vascular Health and Risk Management 2010, 6:69-71

Published Date: 16 February 2010

Review

Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A

Hans-Christoph Rossbach

Vascular Health and Risk Management 2010, 6:59-68

Published Date: 29 January 2010

Review

Inhaled insulin: overview of a novel route of insulin administration

Lucy D Mastrandrea

Vascular Health and Risk Management 2010, 6:47-58

Published Date: 15 January 2010

Review

Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention

Jennifer Vergara-Jimenez, Pierluigi Tricoci

Vascular Health and Risk Management 2010, 6:39-45

Published Date: 2 March 2010

Original Research

Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care

Frederic Kontny, Terje Risanger, Arne Bye, et al

Vascular Health and Risk Management 2010, 6:31-38

Published Date: 15 January 2010

Case report

Successful management of late right ventricular perforation after pacemaker implantation

Amir K Bigdeli, Andres Beiras-Fernandez, Ingo Kaczmarek, et al

Vascular Health and Risk Management 2010, 6:27-30

Published Date: 6 January 2010

Review

Impact of data from recent clinical trials on strategies for treating patients with type 2 diabetes mellitus

Pasquale J Palumbo, Jonathan M Wert

Vascular Health and Risk Management 2010, 6:17-26

Published Date: 6 January 2010

Original Research

Role of ICAM-1 and E-selectin gene polymorphisms in pathogenesis of PAOD in Egyptian patients

Olfat Shaker, Amr Zahra, Ahmed Sayed, et al

Vascular Health and Risk Management 2010, 6:9-15

Published Date: 24 December 2009

Review

Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients

Jamison Wyatt, Shailesh Nandish, Rene Oliveros, et al

Vascular Health and Risk Management 2010, 6:1-8

Published Date: 23 December 2009

Review

Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program

R Michael Kirchner, J Dawn Abbott

Vascular Health and Risk Management 2009, 5:1089-1097

Published Date: 16 December 2009

Review

Nitric oxide and coronary vascular endothelium adaptations in hypertension

Andrew S Levy, Justin CS Chung, Jeffrey T Kroetsch, et al

Vascular Health and Risk Management 2009, 5:1075-1087

Published Date: 16 December 2009

Review

Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea

Jean-Philippe Baguet, Marie Nadra, Gilles Barone-Rochette, et al

Vascular Health and Risk Management 2009, 5:1063-1073

Published Date: 11 December 2009

Case report

Persistent high fever and systemic inflammation induced by percutaneous coronary intervention-related periaortitis

Takamori Kakino, Tomohiro Nakayama, Hideo Yamamoto

Vascular Health and Risk Management 2009, 5:1059-1062

Published Date: 8 December 2009

Review

Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility

Thomas Mengden, Sakir Uen, Peter Bramlage

Vascular Health and Risk Management 2009, 5:1043-1058

Published Date: 30 November 2009

Review

The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences

Venkata Narla, Michael J Blaha, Roger S Blumenthal, et al

Vascular Health and Risk Management 2009, 5:1033-1042

Published Date: 27 November 2009

Review

Mitigating micro- and macro-vascular complications of diabetes beginning in adolescence

Daniel J Moore, Justin M Gregory, Yaa A Kumah-Crystal, et al

Vascular Health and Risk Management 2009, 5:1015-1031

Published Date: 18 November 2009

Original Research

Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India

Krishna K Sharma, Rajeev Gupta, Aachu Agrawal, et al

Vascular Health and Risk Management 2009, 5:1007-1014

Published Date: 20 November 2009

Original Research

Seasonal hematocrit variation and health risks in the adult population of Kinshasa, Democratic Republic of Congo

C Makena Hightower, Joyce D Hightower, Beatriz Y Salazar Vázquez, et al

Vascular Health and Risk Management 2009, 5:1001-1005

Published Date: 17 November 2009

Original Research

Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice

Roland E Schmieder, Markus Schwertfeger, Peter Bramlage

Vascular Health and Risk Management 2009, 5:991-1000

Published Date: 12 November 2009

Review

Vascular health in children and adolescents: effects of obesity and diabetes

Kevin R Short, Piers R Blackett, Andrew W Gardner, et al

Vascular Health and Risk Management 2009, 5:973-990

Published Date: 10 November 2009

Review

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting

Rakesh K Sharma, Hanumanth K Reddy, Vibhuti N Singh, et al

Vascular Health and Risk Management 2009, 5:965-972

Published Date: 9 November 2009

Review

The treatment of diabetic foot infections: focus on ertapenem

Michael Edmonds

Vascular Health and Risk Management 2009, 5:949-963

Published Date: 6 November 2009

Review

Comparative assessment of angiotensin receptor blockers in different clinical settings

Paolo Verdecchia, Fabio Angeli, Salvatore Repaci, et al

Vascular Health and Risk Management 2009, 5:939-948

Published Date: 6 November 2009

Other

Erratum

Zeina AR, Slobodin G, Naschitz JE et al.

Vascular Health and Risk Management 2009, 5:937-938

Published Date: 3 November 2009

Review

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals

Yasushi Saito

Vascular Health and Risk Management 2009, 5:921-936

Published Date: 3 November 2009

Original Research

Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea

Sanja Jelic,  David J Lederer, Tessa Adams, et al.

Vascular Health and Risk Management 2009, 5:909-920

Published Date: 3 November 2009

Review

Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia

Klaus G Parhofer

Vascular Health and Risk Management 2009, 5:901-908

Published Date: 3 November 2009

Original Research

Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes

Nikolaos Östlund Papadogeorgos, Mattias Bengtsson, Majid Kalani

Vascular Health and Risk Management 2009, 5:893-899

Published Date: 28 October 2009

Original Research

Randomized study to compare valsartan ± HCTZ versus amlodipine ± HCTZ strategies to maximize blood pressure control

Dion Zappe, Cheraz Cherif Papst, Philippe Ferber, et al.

Vascular Health and Risk Management 2009, 5:883-892

Published Date: 22 October 2009

Review

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention

Nicholas B Norgard, Mazen Abu-Fadel

Vascular Health and Risk Management 2009, 5:873-882

Published Date: 21 October 2009

Review

Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies

Matthias Meier, Michael Hummel

Vascular Health and Risk Management 2009, 5:859-871

Published Date: 19 October 2009

Original Research

Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjects